All Publications from Prof. Dr. med. Jan Kassubek

-> Link zu Pubmed

2023 / in press

  1. F. Marxreiter, V. Lambrecht, A. Mennecke, J. Hanspach, J. Jukic, M. Regensburger, J. Herrler, A. German, J. Kassubek, G. Grön, H.-P. Müller, F. B. Laun, A. Dörfler, J. Winkler, M. A. Schmidt: “Parkinson´s disease or multiple system atrophy: separation by quantitative susceptibility mapping” (Therapeutic Advances in Neurological Disorders (2023); in press)

 

Profilbild von Prof. Dr. med. Jan Kassubek

Prof. Dr. med. Jan Kassubek

Kontakt Details

  1. R. Kassubek, D. Weinstock, A. Behler, H.-P. Müller, L. Dupuis, J. Kassubek, A. C. Ludolph: “Morphological alterations of the hypothalamus in idiopathic intracranial hypertension” (Therapeutic Advances in Chronic Disease (2022); 13: 20406223221141354 (1-10))

  2. R. Kassubek, B. Lindner-Pfleghar, I. E. Virvidaki, J. Kassubek, K. Althaus, A. M. Weber, G. Dimakopoulos, H. Milionis, G. Nasios: ”A prospective validation study of the functional bedside aspiration screen with endoscopy: is it clinically applicable in acute stroke?” (Journal of Clinical Medicine (2022); 11 (23): 7087 (1-12))

  3. K. Althaus, M. Kasel, A. C. Ludolph, J. Kassubek, R. Kassubek: “HARM revisited: etiology of subarachnoid hyperintensities in brain FLAIR MRI” (International Journal of Stroke (2022); 17 (10): 1121-1128)

  4. T. D. Kocar, A. Behler, C. Leinert, M. Denkinger, A. C. Ludolph, H.-P. Müller, J. Kassubek: “Artificial neural networks for non-linear age correction of diffusion metrics in the brain” (Frontiers in Aging Neuroscience (2022); 14: 999787 (1-11))

  5. J. Kassubek: „Editorial: Insights in applied neuroimaging 2021“ (Frontiers in Neurology (2022); 13: 1048674 (1-3))

  6. J. Kassubek: “Editorial: Applied neuroimaging - Case report collection 2021” (Frontiers in Neurology (2022); 13: 1027252 (1-2))

  7. W. P. Ruf, A. Palmer, L. Dörfer, D. Wiesner, E. Buck, V. Grozdanov, J. Kassubek, L. Dimou, A. C. Ludolph, M. Huber-​Lang, K. M. Danzer: “Thoracic trauma promotes alpha-​Synuclein oligomerization in murine Parkinson's disease” (Neurobiology of Disease (2022); 174: 105877 (1-9))

  8. V. Mylius, S. Perez Lloret, C. S. Brook, M. T. Krüger, S. Hägele-​Link, R. Gonzenbach, J. Kassubek, S. Bohlhalter, J. P. Lefaucheur, L. Timmermann, G. Kägi, F. Brugger, D. Ciampi de Andrade, J. C. Möller: “Die neue Parkinson Schmerz Klassifikation (PSK)” (Nervenarzt (2022); 93 (10): 1019-1027)

  9. A. Behler, D. Lulé, A. C. Ludolph, J. Kassubek*, H.-P. Müller* (* shared senior authorship): “Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: power calculations for group studies” (Frontiers in Neuroscience (2022); 16: 929151 (1-10))

  10. F. D. Juengling, F. Wuest, S. Kalra, F. Agosta, R. Schirrmacher, A. Thiel, W. Thaiss, H.-P. Müller, J. Kassubek: “Simultaneous PET/MRI - the future gold standard for characterizing motor neuron disease? A clinico-​radiological and neuroscientific perspective” (Frontiers in Neurology (2022); 13: 890425 (1-14))

  11. A. E. Lang, A. D. Siderowf, E. A. Macklin, W. Poewe, D. J. Brooks, H. H. Fernandez, O. Rascol, N. Giladi, F. Stocchi, C. M. Tanner, R. B. Postuma, D. K. Simon, E. Tolosa, B. Mollenhauer, J. M. Cedarbaum, K. Fraser, J. Xiao, K. C. Evans, D. L. Graham, I. Sapir, J. Inra, R. M. Hutchison, M. Yang, T. Fox, S. Budd Haeberlein, T. Dam; SPARK Investigators [incl. J. Kassubek]: “Trial of cinpanemab in early Parkinson's Disease” (New England Journal of Medicine (2022); 387 (5): 408-420)

  12. A. Huss, A. Abdelhak, B. Mayer, H. Tumani, H.-P. Müller, K. Althaus, J. Kassubek, M. Otto, A. C. Ludolph, D. Yilmazer-​Hanke, H. Neugebauer: “Association of serum GFAP with functional and neurocognitive outcome in sporadic small vessel disease” (Biomedicines (2022);10 (8): 1869 (1-15))

  13. A. Behler, H.-P. Müller, A. C. Ludolph, D. Lulé, J. Kassubek: “A multivariate Bayesian classification algorithm for cerebral stage prediction by diffusion tensor imaging in amyotrophic lateral sclerosis” (NeuroImage Clinical (2022); 35: 103094 (1-7))

  14. H.-P. Müller, A. M. Nagel, F. Keidel, A. Wunderlich, A. Hübers, L. V. Gast, A. C. Ludolph, M. Beer, J. Kassubek: “Relaxation-​weighted 23Na magnetic resonance imaging maps regional patterns of abnormal sodium concentrations in amyotrophic lateral sclerosis” (Therapeutic Advances in Chronic Disease (2022); 13: 20406223221109480 (1-8))

  15. M. Ponce-​de-Leon, A. Hannemann, J. Linseisen, M. Nauck, M. M. Lerch, R. Bülow, H. Völzke, N. Friedrich, J. Kassubek, H.-P. Müller, S. E. Baumeister, C. Meisinger: “Links between ectopic and abdominal fat and systemic inflammation: New insights from the SHIP-​Trend study” (Digestive and Liver Disease (2022); 54 (8): 1030-1037)

  16. J. Kassubek: “Advanced network neuroimaging as an approach to unravel the pathophysiology of restless legs syndrome” (Sleep (2022); 45 (7): zsac125 (1-2))

  17. A. Behler, H.-P. Müller, K. Del Tredici, H. Braak, A. C. Ludolph, D. Lulé, J. Kassubek: “Multimodal in vivo staging in amyotrophic lateral sclerosis using artificial intelligence” (Annals of Clinical and Translational Neurology (2022); 9 (7): 1069-1079)

  18. S. Rauch, H.-P. Müller, J. Dreyhaupt, A. C. Ludolph, J. Kassubek, K. Althaus: “Andexanet alfa for reversal of factor Xa inhibitors in intracranial hemorrhage: observational cohort study” (Journal of Clinical Medicine (2022); 11 (12): 3399 (1-9))

  19. M. Münch, H.-P. Müller, A. Behler, A. C. Ludolph, J. Kassubek: “Segmental alterations of the corpus callosum in motor neuron disease: a DTI and texture analysis in 575 patients” (NeuroImage Clinical (2022); 35: 103061 (1-10))

  20. L. Lampe, S. Niehau, H.-J. Huppertz, A. Merola, J. Reinelt, K. Mueller, S. Anderl-​Straub, K. Fassbender, K. Fliessbach, H. Jahn, J. Kornhuber, M. Lauer, J. Prudlo, A. Schneider, M. Synofzik, A. Danek, J. Diehl-​Schmid, M. Otto, A. Villringer, K. Egger, E. Hattingen, R. Hilker-​Roggendorf, A. Schnitzler, M. Südmeyer, W. Oertel, J. Kassubek, G. Höglinger, M. L. Schroeter: “Comparative analysis of machine learning algorithms for multi-​syndrome classification of neurodegenerative syndromes” (Alzheimer's Research & Therapy (2022); 14 (1): 62 (1-13))

  21. G. Nasios, L. Messinis, E. Dardiotis, J. Kassubek: “Communication, feeding and swallowing disorders in neurological diseases” (Behavioral Neurology (2022); 2022: 985142 (1-4))

  22. A. Rosenbohm, K. Del Tredici, H. Braak, H.-J. Huppertz, A. C. Ludolph, H.-P. Müller, J. Kassubek: “Involvement of cortico-​efferent tracts in flail arm syndrome: a tract-​of-interest-based DTI study” (Journal of Neurology (2022); 269 (5): 2619-2626)

  23. I. Vernikouskaya, H.-P. Müller, D. Felbel, F. Roselli, A. C. Ludolph, J. Kassubek*, V. Rasche* (* shared senior authorship): “Body fat compartment determination by encoder-​decoder convolutional neural network: application to amyotrophic lateral sclerosis” (Scientific Reports (2022); 12: 5513 (1-9))

  24. J. Michels, H. van der Wurp, E. Kalbe, S. Rehberg, A. Storch, K. Linse, C. Schneider, S. Gräber, D. Berg, J. Dams, M. Balzer-​Geldsetzer, R. Hilker-​Roggendorf, C. Oberschmidt, S. Baudrexel, K. Witt, N. Schmidt, G. Deuschl, B. Mollenhauer, C. Trenkwalder, I. Liepelt-​Scarfone, A. Spottke, S. Roesken, U. Wüllner, H. U. Wittchen, O. Riedel, J. Kassubek, R. Dodel, J. B. Schulz, A. S. Costa, K. Reetz: “Long-​term cognitive decline related to the motor phenotype in Parkinson’s Disease” (Journal of Parkinson`s Disease (2022); 12 (3): 905-916)

  25. R. Hörner, J. Kassubek, J. Dreyhaupt, A. C. Ludolph: “The spectrum and differential diagnosis of acquired ocular motor nerve palsies: a clinical study of 502 patients” (Journal of Neurology (2022); 269 (4): 2140-2148)

  26. H. Hebestreit, C. Zeidler, C. Schippers, M. de Zwaan, J. Deckert, P. Heuschmann, C. Krauth, M. Bullinger, A. Berger, M. Berneburg, L. Brandstetter, A. Deibele, J. Dieris-​Hirche, H. Graessner, H. Gündel, S. Herpertz, G. Heuft, A. M. Lapstich, T. Lücke, T. Maisch, C. Mundlos, A. Petermann-​Meyer, S. Müller, S. Ott, L. Pfister, J. Quitmann, M. Romanos, F. Rutsch, K. Schaubert, K. Schubert, J. B. Schulz, S. Schweiger, O. Tüscher, K. Ungethüm, T. O. F. Wagner, K. Haas; ZSE-​DUO working group [incl. J. Kassubek]: “Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-​DUO): study protocol for a controlled multi-​center cohort study” (Orphanet Journal of Rare Diseases (2022); 17 (1):47 (1-12)

  27. D. Lulé, S. Michels, J. Finsel, H. Braak, K. Del Tredici, J. Strobel, A. J. Beer, I. Uttner, H.-P. Müller, J. Kassubek, F. D. Juengling, A. C. Ludolph: “Clinicoanatomical substrates of selfish behaviour in amyotrophic lateral sclerosis – an observational cohort study” (Cortex (2022); 146: 261-270)

  28. D. Charissé, G. Erus, R. Pomponio, M. Gorges, N. Schmidt, C. Schneider, I. Liepelt-​Scarfone, O. Riedel, K. Reetz, J. B. Schulz, D. Berg, A. Storch, K. Witt, R. Dodel, E. Kalbe, J. Kassubek, R. Hilker-​Roggendorf, S. Baudrexel: ”Brain age and Alzheimer's-​like atrophy are domain-​specific predictors of cognitive impairment in Parkinson's disease” (Neurobiology of Aging (2022); 109: 31-42)

  1. S. Anderl-Straub, L. Lausser, J. Lombardi, I. Uttner, K. Fassbender, K. Fliessbach, H. J. Huppertz, H. Jahn, J. Kornhuber, H. Obrig, A. Schneider, E. Semler, M. Synofzik, A. Danek, J. Prudlo, J. Kassubek, B. Landwehrmeyer, M. Lauer, A. E. Volk, J. Wiltfang, J. Diehl-Schmid, A. C. Ludolph, M. Schroeter, H. A. Kestler, M. Otto: ”Predicting disease progression in behavioral variant frontotemporal dementia”(Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring (2021); 13: e12262 (1-11))
  2. H. Jackson, J. Anzures-Cabrera, K. I. Taylor, G. Pagano; PASADENA Investigators; Prasinezumab Study Group [incl. J. Kassubek]: “Hoehn and Yahr stage and striatal Dat-SPECT uptake are predictors of Parkinson's Disease motor progression” (Frontiers in Neuroscience (2021); 15: 765765 (1-10))
  3. L. Bârlescu, H.-P. Müller, I. Uttner, A. C. Ludolph, E. H. Pinkhardt, H.-J. Huppertz, J. Kassubek:  “Segmental alterations of the corpus callosum in progressive supranuclear palsy: a multiparametric MRI study”  (Frontiers in Aging Neuroscience (2021); 13: 720634 (1-9))
  4. T. D. Kocar, A. Behler, A. C. Ludolph, H.-P. Müller, J. Kassubek: “Multiparametric microstructural MRI and machine learning classification yields high diagnostic accuracy in amyotrophic lateral sclerosis: proof of concept”(Frontiers in Neurology (2021); 12: 745475 (1-7))
  5. A. Rosenbohm, R. Peter, J. Dorst, J. Kassubek, D. Rothenbacher, G. Nagel, A. C. Ludolph: “Life-course of physical activity and risk and prognosis of amyotrophic lateral sclerosis (ALS) in a German ALS registry” (Neurology (2021); 97 (19): e1955-e1963)
  6. D. Bhatia, V. Grozdanov, W. P. Ruf, J. Kassubek, A. C. Ludolph, J. H. Weishaupt, K. M. Danzer: “T-cell dysregulation is associated with disease severity in Parkinson's Disease” (Journal of Neuroinflammation (2021); 18 (1): 250 (1-10))
  7. J. Lombardi, B. Mayer, E. Semler, Sarah Anderl-Straub, I. Uttner, J. Kassubek, J. Diehl-Schmid, A. Danek, J. Levin, K. Fassbender, K. Fliessbach, A. Schneider, H.-J. Huppertz, H. Jahn, A. Volk, J. Kornhuber, B. Landwehrmeyer, M. Lauer, J. Prudlo, J. Wiltfang, M. L. Schroeter, A. Ludolph, M. Otto, FTLD consortium: “Quantifying progression in primary progressive aphasia with structural neuroimaging” (Alzheimer’s & Dementia (2021); 17 (10): 1595-1609)           
  8. T. D. Kocar, H.-P. Müller, A. C. Ludolph, J. Kassubek: “Feature selection from magnetic resonance imaging data in ALS: a systematic review” (Therapeutic Advances in Chronic Disease (2021); 12: 20406223211051002 (1-21))
  9. X.-Z. Jia, N. Zhao, H.-M. Dong, J.-W. Sun, M. Barton, R. Burciu, N. Carrière, A. Cerasa, B.-Y. Chen, J. Chen, S. Coombes, L. Defebvre, C. Delmaire, K. Dujardin, F. Esposito, G.-G. Fan, F. Di Nardo, Y.-X. Feng, B. W. Fling, S. Garg, M. Gilat, M. Gorges, S.-L. Ho, F. B. Horak, X. Hu, X.-F. Hu, B. Huang, P.-Y. Huang, Z.-J. Jia, C. Jones, J. Kassubek, L. Krajcovicova, A. Kurani, J. Li, Q. Li, A.-P. Liu, B. Liu, H. Liu, W.-G. Liu, R. Lopes, Y.-T. Lou, W. Luo, T. Madhyastha, N.-N. Mao, G. McAlonan, M. J. McKeown, S. Y. Y. Pang, A. Quattrone, I. Rektorova, A. Sarica, H.-F. Shang, J. M. Shine, P. Shukla, T. Slavicek, X.-P. Song, G. Tedeschi, A. Tessitore, D. Vaillancourt, J. Wang, J. Wang, Z. J. Wang, L.-Q. Wei, X. Wu, X.-J. Xu, L. Yan, J. Yang, W.-Q. Yang, N.-L. Yao, D.-L. Zhang, J.-Q. Zhang, M.-M. Zhang, Y.-L. Zhang, C.-H. Zhou, C.-G. Yan, X.-N. Zuo, M. Hallett, T. Wu, Y.-F. Zang: ”Small P values may not yield robust findings: an example using REST-meta-PD” (Science Bulletin (2021); 66: 2148-2152)
  10. G. Pagano, F. G. Boess, K. I. Taylor, B. Ricci, B. Mollenhauer, W. Poewe, A. Boulay, J. Anzures-Cabrera, A. Vogt, M. Marchesi, A. Post, T. Nikolcheva, G. G. Kinney, W. M. Zago, D. K. Ness, H. Svoboda, M. Britschgi, S. Ostrowitzki, T. Simuni, K. Marek, M. Koller, J. Sevigny, R. Doody, P. Fontoura, D. Umbricht, A. Bonni; PASADENA Investigators; Prasinezumab Study Group [incl. J. Kassubek]: “A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data” (Frontiers in Neurology (2021);12:705407 (1-17))
  11. A. Ophey, S. Wolfsgruber, S. Roeske, A. Polcher, A. Spottke, L. Frölich, M. Hüll, F. Jessen, J. Kornhuber, W. Maier, O. Peters, A. Ramirez, J. Wiltfang, I. Liepelt-Scarfone, S. Becker, D. Berg, J. B. Schulz, K. Reetz, J. Wojtala, J. Kassubek, A. Storch, M. Balzer-Geldsetzer, R. Hilker-Roggendorf, K. Witt, B. Mollenhauer, C. Trenkwalder, H.-U. Wittchen, O. Riedel, R, Dodel, M. Wagner, E. Kalbe: ”Cognitive profiles of patients with mild cognitive impairment due to Alzheimer’s versus Parkinson’s disease defined using a base rate approach: implications for neuropsychological assessments” (Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring (2021); 13: e12223 (1-12))
  12. A. Hübers, J. Kassubek, H.-P. Müller, N. Broc, J. Dreyhaupt, A. C. Ludolph: “The ipsilateral silent period: an early diagnostic marker of callosal disconnection in ALS” (Therapeutic Advances in Chronic Disease (2021); 12: 20406223211044072 (1-7))
  13. D. Lehrieder, K. Layer, H.-P. Müller, V. Rücker, J. Kassubek, E. Juettler, H. Neugebauer: “Association of infarct volume before hemicraniectomy and outcome after malignant infarction” (Neurology (2021); 96 (22): e2704-e2713)
  14. R. Lillig, A. Ophey, J. B. Schulz, K. Reetz, J. Wojtala, A. Storch, I. Liepelt-Scarfone, S. Becker, D. Berg, M. Balzer-Geldsetzer, J. Kassubek, R. Hilker-Roggendorf, K. Witt, B. Mollenhauer, C. Trenkwalder, S. Roeske, H.-U. Wittchen, O. Riedel, R. Dodel, E. Kalbe:“A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson’s disease: evidence from the LANDSCAPE study”(Parkinsonism and Related Disorders (2021); 90: 90-97)
  15. K. Althaus, J. Dreyhaupt, S. Hyrenbach, E. H. Pinkhardt, J. Kassubek, A. C. Ludolph:“MRI as a first-line imaging modality in acute ischemic stroke: a sustainable concept”(Therapeutic Advances in Neurological Disorders (2021); 14: 17562864211030363 (1-12))
  16. J. Wunderlich, A. Behler, J. Dreyhaupt, A. C. Ludolph, E. H. Pinkhardt, J. Kassubek: “Diagnostic value of video-oculography in progressive supranuclear palsy: a controlled study in 100 patients” (Journal of Neurology (2021); 268 (9): 3467-3475)
  17. A. Behler, A. Knehr, J. Finsel, M. S. Kunz, C. Lang, K. Müller, H.-P. Müller, E. H. Pinkhardt, A. C. Ludolph, D. Lulé, J. Kassubek: “Eye movement alterations in presymptomatic C9orf72 expansion gene carriers” (Journal of Neurology (2021); 268 (9): 3390-3399)
  18. H.-P. Müller, A. Behler, G. B. Landwehrmeyer, H.-J. Huppertz, J. Kassubek: “How to arrange follow-up time-intervals for longitudinal brain MRI studies in neurodegenerative diseases”(Frontiers in Neuroscience (2021); 15: 682812 (1-8))
  19. R. Rehman, L. Tar, A. J. Olamide, Z. Li, J. Kassubek, T. Böckers, J. Weishaupt, A. Ludolph, D. Wiesner, F. Roselli: “Acute TBK1/IKK-ε inhibition enhances the generation of disease-associated microglia-like phenotype upon cortical stab-wound injury” (Frontiers in Aging Neuroscience (2021); 13: 684171 (1-20))
  20. P. Lingor, J. C. Koch, J. M. Statland, S. Hussain, C. Hennecke, J. Wuu, T. Langbein, R. Ahmed, R. Günther, B. Ilse, J. Kassubek, K. Kollewe, J. Kuttler, A. Leha, T. Lengenfeld, T. Meyer, C. Neuwirth, R. Tostmann, M. Benatar: “Challenges and opportunities for multi-national investigator-initiated clinical trials for ALS: European and United States collaborations” (Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2021); 22 (5-6): 419-425)
  21. A. Behler, J. Kassubek, H.-P. Müller: “Age-related alterations in DTI metrics in the human brain – consequences for age correction” (Frontiers in Aging Neuroscience (2021); 13: 682109 (1-15))
  22. D. Bayer, S. Antonucci, H.-P. Müller, R. Saad, L. Dupuis, V. Rasche, T. M. Böckers, A. C. Ludolph, J. Kassubek, F. Roselli: “Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and human patients” (Translational Neurodegeneration (2021); 10 (1): 17 (1-17))
  23. J. Scekic-Zahirovic, I. Sanjuan-Ruiz, V. Kan, S. Megat, P. De Rossi, S. Dieterlé, R. Cassel, M. Jamet, P. Kessler, D. Wiesner, L. Tzeplaeff, V. Demais, S. Sahadevan, K. M. Hembach, H.-P. Müller, G. Picchiarelli, N. Mishra, S. Antonucci, S. Dirrig-Grosch, J. Kassubek, V. Rasche, A. Ludolph, A.-L. Boutillier, F. Roselli, M. Polymenidou, C. Lagier-Tourenne, S. Liebscher, L. Dupuis: “Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects”(Nature Communications (2021); 12 (1): 3028 (1-19))
  24. J. Kassubek: „Probiotika bessern Parkinson-Obstipation“ (MMW Fortschritte der Medizin (2021); 163 (12): 26)
  25. A. Hübers, B. Böckler, A. Abaei, V. Rasche, D. Lulé, E. Ercan, N. Doorenweerd, H.-P. Müller, J. Dreyhaupt, T. Kammer, A. C. Ludolph, I. Ronen, J. Kassubek: „Functional and structural impairment of transcallosal motor fibres in ALS: a study using transcranial magnetic stimulation, diffusion tensor imaging, and diffusion weighted spectroscopy“ (Brain Imaging and Behavior (2021); 15 (2): 748-757)           
  26. H.-P. Müller, D. Lulé, F. Roselli, A. Behler, A. C. Ludolph, J. Kassubek: “Segmental involvement of the corpus callosum in C9orf72-associated ALS: a tract of interest-based DTI study” (Therapeutic Advances in Chronic Disease (2021); 12: 20406223211002969 (1-9))
  27. R. Kassubek, H.-P. Müller, A. Thiele, J. Kassubek, H. G. Niessen: “Advanced magnetic resonance imaging to support clinical drug development for malignant glioma” (Drug Discovery Today (2021); 26 (2): 429-441)
  28. D. Lehmann Urban, M. Mohamed, A. C. Ludolph, J. Kassubek*, A. Rosenbohm* (*shared senior authorship): “The value of qualitative muscle MRI in the diagnostic procedures of myopathies: a biopsy-controlled study in 191 patients” (Therapeutic Advances in Neurological Disorders (2021); 14: 1756286420985256 (1-11))
  29. S. Jesse, H. J. Huppertz, A. C. Ludolph, J. Kassubek: “Focal cortical dysplasia – relevant for seizures in Phelan McDermid syndrome?” (Pediatric Neurology (2021); 115: 7-9)
  30. W. H. Jost, G. Ebersbach, J. Kassubek, S. Klebe, L. Tönges: „Neue Therapieoption zur individualisierten Titration von Levodopa“ (Fortschritte der Neurologie – Psychiatrie (2021); 89 (1-2): 23-28)
  1. L. A. Bârlescu, J. Kassubek:  „Diagnostik und Therapie von Tremorsyndromen“ (Fortschritte der Neurologie – Psychiatrie (2020); 88 (12): 794-814)
  2. S. Stösser, L. Ullrich, J. Kassubek, A. C. Ludolph, M. Schocke, H. Neugebauer: “Recent silent infarcts do not increase the risk of hemorrhage after intravenous thrombolysis” (European Journal of Neurology (2020); 27 (12): 2483–2490)
  3. M. Senel, S. Abu-Rumeileh, D. Michel, T. Garibashvili, K. Althaus, J. Kassubek, M. Otto: “Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement” (European Journal of Neurology (2020); 27 (11): 2378-2380)
  4. D. Berg, K. Eggert, B. Haslinger, J. Kassubek, B. Mollenhauer, K. Reetz, A. Rogge, E. Schaeffer, L. Tönges, K. E. Zeuner: “Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?” (Neurological Research and Practice (2020); 2: 31 (1-3))
  5. D. Lulé, H.-P. Müller, J. Finsel, P. Weydt, A. Knehr, I. Winroth, P. M. Andersen, J. H. Weishaupt, I. Uttner, J. Kassubek*, A. C. Ludolph* (*shared senior authorship): “Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers – a developmental disorder” (Journal of Neurology, Neurosurgery, and Psychiatry (2020); 91 (11): 1195-1200)
  6. S. Abu-Rumeileh, T. Garibashvili, W. Ruf, T. Fangerau, J. Kassubek, K. Althaus, M. Otto, M. Senel: “Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19” (Journal of the Neurological Sciences (2020); 418: 117106 (1-2))
  7. H.-P. Müller, F. Roselli, V. Rasche, J. Kassubek: “Diffusion tensor imaging-based studies at the group-level applied to animal models of neurodegenerative diseases” (Frontiers in Neuroscience (2020); 14: 734 (1-20))
  8. C. Buhmann, J. Kassubek, W. H. Jost: “Management of pain in Parkinson’s disease” (Journal of Parkinson's Disease (2020); 10 (s1): S37-S48)
  9. S. Kalra, H.-P. Müller, A. Ishaque, L. Zinman, L. Korngut, A. Genge, C. Beaulieu, R. Frayne, S. J. Graham, J. Kassubek: “A prospective harmonized multicentre DTI study of cerebral white matter degeneration in ALS” (Neurology (2020); 95 (8): e943-e952)
  10. T. D. Kocar, H.-P. Müller, J. Kassubek: „Differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis” (Therapeutic Advances in Neurological Disorders (2020); 13: 1756286420941670 (1-10))
  11. A. Huss, M. Senel, A. Abdelhak, B. Mayer, J. Kassubek, A. C. Ludolph, M. Otto, H. Tumani: “Longitudinal serum neurofilament levels of multiple sclerosis patients before and after treatment with first-line immunomodulatory therapies” (Biomedicines (2020); 8 (9): E312 (1-12))
  12. J. Dorst, J. Schuster, J. Dreyhaupt, S. Witzel, J. H. Weishaupt, J. Kassubek, U. Weiland, S. Petri, T. Meyer, T. Grehl, A. Hermann, B. Jordan, J. Grosskreutz, D. Zeller, M. Boentert, B. Schrank, J. Prudlo, A. S. Winkler, S. Gorbulev, F. Roselli, L. Dupuis, M. Otto, A. C. Ludolph: “Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis“ (Journal of Neurology, Neurosurgery, and Psychiatry (2020); 91 (9): 1007-1009)
  13. E. H. Pinkhardt, Y. Ding, S. Slotnick, J. Kassubek, A. C. Ludolph, S. Glazman, I. Selesnick, I. Bodis-Wollner: “The intrinsically restructured fovea  is correlated with contrast sensitivity loss in Parkinson`s Disease” (Journal of Neural Transmission (2020); 127 (9): 1275-1283)
  14. J. Fischer, H. Völzke, J. Kassubek, H.-P. Müller, J.-P. Kühn, M. Nauck, N. Friedrich, S. Zylla: “Associations of a panel of adipokines with fat deposits and metabolic phenotypes in a general population” (Obesity (2020); 28 (8): 1550-1559)
  15. I. Ratjen, J. Morze, J. Enderle, M. Both, J. Borggrefe, H.-P. Müller, J. Kassubek, M. Koch, W. Lieb: “Adherence to a plant-based diet in relation to adipose tissue volumes and liver fat content” (American Journal of Clinical Nutrition (2020); 112 (2): 354-363)
  16. H.-P. Müller, K. Del Tredici, D. Lulé, K. Müller, J. H. Weishaupt, A. C. Ludolph, J. Kassubek: “In vivo histopathological staging in C9orf72-associated ALS: a tract of interest DTI study” (NeuroImage Clinical (2020); 27: 102298 (1-6))
  17. H.-P. Müller, J. Dreyhaupt, F. Roselli, M. Schlecht, A. C. Ludolph, H.-J. Huppertz, J. Kassubek: „Focal alterations of the callosal area III in primary lateral sclerosis: an MRI planimetry and texture analysis” (NeuroImage Clinical (2020); 26: 102223 (1-8))
  18. C. Schönfeldt-Lecuona, T. Kregel, A. Schmidt, J. Kassubek, J. Dreyhaupt, R. Freudenmann, B. J. Connemann, M. Gahr, E. H. Pinkhardt: “Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder” (Schizophrenia Research (2020); 219: 5-12)
  19. A. Abdelhak, A. Huss, A. Brueck, U. Sebert, B. Mayer, H.-P. Müller, H. Tumani, M. Otto, D. Yilmazer-Hanke, A. C. Ludolph, J. Kassubek, E. Pinkhardt, H. Neugebauer: „Optical coherence tomography- and cerebrospinal fluid-based assessment of retinal vascular pathology in cerebral small vessel disease”  (Neurological Research and Practice (2020); 2: 13 (1-11))
  20. A. Rosenbohm, D. Buckert, J. Kassubek, W. Rottbauer, A. C. Ludolph, P. Bernhardt: “Sporadic inclusion body myositis: no specific cardiac involvement in cardiac magnetic resonance tomography” (Journal of Neurology (2020); 267 (5): 1407-1413)
  21. D. G. Grosset, R. Dhall, T. Gurevich, J. Kassubek, W. H. Poewe, O. Rascol, M. Rudzinska, J. Cormier, A. Sedkov, C. Oh: “Inhaled levodopa in Parkinson’s disease patients with OFF periods: a randomized 12-month pulmonary safety study” (Parkinsonism and Related Disorders (2020); 71: 4-10)
  22. P. Barschke, P. Öckl, P. Steinacker, M. H. D. Rami Al Shweiki, J. H Weishaupt, G. B. Landwehrmeyer, S. Anderl-Straub, P. Weydt, J. Diehl-Schmid, A. Danek, J. Kornhuber, M. L. Schroeter, J. Prudlo, H. Jahn, K. Fassbender, M. Lauer, E. L. van der Ende, J. C. van Swieten, A. E. Volk, A. C. Ludolph, M. Otto, the German FTLD Consortium [incl. J. Kassubek]: “Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion” (Journal of Neurology, Neurosurgery, and Psychiatry (2020); 91 (5): 503-511)
  23. M. Gorges, M. S. Kunz, H.-P. Müller, I. Liepelt-Scarfone, A. Storch, R. Dodel, R. Hilker-Roggendorf, LANDSCAPE Consortium, D. Berg, E. Kalbe, H. Braak, K. Del Tredici, S. Baudrexel, H.-J. Huppertz, J. Kassubek: „Longitudinal brain atrophy distribution in advanced Parkinson’s disease: what makes the difference in ‘cognitive status’ converters?” (Human Brain Mapping (2020); 41 (6): 1416-1434)
  24. D. Yilmazer-Hanke, T. Mayer, H.-P. Müller, H. Neugebauer, A. Abaei, A. Scheuerle, J. Weis, K. M. E. Forsberg, K. Althaus, J. Meier, A. C. Ludolph, K. Del Tredici, H. Braak, J. Kassubek*, Volker Rasche* (* shared senior authorship): "Histological correlates of postmortem ultra-high-resolution single-section MRI in cortical cerebral microinfarcts” (Acta Neuropathologica Communications (2020); 8 (1): 33 (1-18))
  25. R. Yilmaz, K. Müller, D. Brenner, A. E. Volk, G. Borck, A. Hermann, T. Meitinger, T. M. Strom, K. M. Danzer, A. C. Ludolph, P. M. Andersen, J. H. Weishaupt; German ALS Network MND-NET [incl. J. Kassubek]: “SQSTM1/p62 variants in 486 patients with familial ALS from Germany and Sweden” (Neurobiology of Aging (2020); 87: 139.e9-139.e15)
  26. T. Ballarini, F. Albrecht, K. Mueller, R. Jech, J. Diehl-Schmid, K. Fliessbach, J. Kassubek, M. Lauer, K. Fassbender, A. Schneider, M. Synofzik, J. Wiltfang, FTLD Consortium Germany, M. Otto, M. L. Schroeter: “Disentangling brain functional network remodeling in corticobasal syndrome – a multimodal MRI study” (NeuroImage Clinical (2020); 25: 102112 (1-11))
  27. J. Kassubek, H.-P. Müller: “Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis” (Expert Review of Neurotherapeutics (2020); 20 (3): 237-249)
  28. A. Jennings, M. Koch, M. K. Jensen, C. Bang, J. Kassubek, H.-P. Müller, U. Nöthlings, A. Franke, W. Lieb, A. Cassidy: „The role of the gut microbiome in the association between habitual anthocyanin intake and visceral abdominal fat in population-level analysis” (American Journal of Clinical Nutrition (2020); 111 (2): 340-350)
  29. A. C. Ludolph, J. Dorst, J. Dreyhaupt, J. H. Weishaupt, J. Kassubek, U. Weiland, T. Meyer, S. Petri, A. Hermann, A. Emmer, J. Grosskreutz, T. Grehl, D. Zeller, M. Boentert, B. Schrank, J. Prudlo, A. S. Winkler, S. Gorbulev, F. Roselli, J. Schuster, L. Dupuis, for the LIPCAL-ALS Study Group: “Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis” (Annals of Neurology (2020); 87 (2): 206-216)
  30. G. Respondek, M. J. Grimm, I. Piot, T. Arzberger, Y. Compta, E. Englund, L. W. Ferguson, E. Gelpi, S. Roeber, A. Giese, M. Grossman, D. J. Irwin, W. G. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, J. C. van Swieten, C. Troakes, G. U. Höglinger; Movement Disorder Society-Endorsed Progressive Supranuclear Palsy Study Group [incl. J. Kassubek]: “Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies” (Movement Disorders (2020); 35 (1): 171-176)
  31. A. Hübers, H.-J. Huppertz, S. B. Wortmann, J. Kassubek: "Mutation of the WARS2 gene as the cause of a severe hyperkinetic movement disorder" (Movement Disorders Clinical Practice (2020); 7 (1): 88–90)
  32. S. Jesse, H.-P. Müller, M. Schoen, H. Asoglu, J. Bockmann, H.-J. Huppertz, V. Rasche, A. C. Ludolph, T. M. Boeckers, J. Kassubek: "Severe white matter damage SHANK3 deficiency: a human and translational study” (Annals of Clinical and Translational Neurology (2020); 7 (1): 46-58)
  1. J. Shu, H. Neugebauer, F. Li, D. Lulé, H.-P. Müller, J. Zhang, A. C. Ludolph, Y. Huang, J. Kassubek*, W. Zhang* (*shared senior authorship): „Clinical and neuroimaging disparity between Chinese and German patients with cerebral small vessel disease: a comparative study” (Scientific Reports (2019); 9 (1): 20015 (1-7))                                                 
  2. H.-P. Müller, M. Gorges, K. Del Tredici, A. C. Ludolph, J. Kassubek: "The same cortico-efferent tract involvement in progressive bulbar palsy and in `classical' ALS: a tract of interest-based MRI study" (NeuroImage Clinical (2019); 24: 101979 (1-5))                                             
  3. D. Brenner, A. Rosenbohm, R. Yilmaz, K. Müller, T. Grehl, S. Petri, T. Meyer, J. Grosskreutz, P. Weydt, W. Ruf, C. Neuwirth, M. Weber, S. Pinto, K. G. Claeys, B. Schrank, B. Jordan, A. Knehr, K. Günther, A. Hübers, D. Zeller, C. Kubisch, S. Jablonka, M. Sendtner, T. Klopstock, M. de Carvalho, A. Sperfeld, G. Borck, A. E. Volk, J. Dorst, J. Weis, M. Otto, J. Schuster, K. Del Tredici, H. Braak, K. M. Danzer, A. Freischmidt, T. Meitinger, A. C. Ludolph, P. M. Andersen, J. H. Weishaupt, German ALS Network MND-NET [incl. J. Kassubek]: “Reply: Adult-onset distal spinal muscular atrophy: a new phenotype associated with KIF5A mutations” (Brain (2019); 142 (12): e67)                                                                              
  4. M. Gorges, B. Kuntz, K. Del Tredici, D. G. Schmidt, H.-P. Müller, A. C. Ludolph, L. Dupuis, J. Kassubek: „Morphological MRI investigations of the hypothalamus in 232 individuals with Parkinson’s disease” (Movement Disorders (2019); 34 (10): 1566-1570)                                         
  5. W. Becker, M. Gorges, D. Lulé, E.  Pinkhardt, A. C. Ludolph, J. Kassubek: “Saccadic intrusions in amyotrophic lateral sclerosis (ALS)” (Journal of Eye Movement Research (2019); 12 (6): 8 (1-17))                     
  6. C. Vollmuth, S. Stoesser S, H. Neugebauer, A. Hansel, J. Dreyhaupt, A. C. Ludolph, J. Kassubek, K. Althaus: “MR-imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke” (Journal of Neurology (2019); 266 (12): 3058-3064)                                     
  7. E. H. Pinkhardt, H. Liu, D. Ma, J. Chen, A. Pachollek, M. S. Kunz, J. Kassubek, A. C. Ludolph, Y. Huang, H. Chen, G. B. Landwehrmeyer, Z. Wang, W. Su: „Olfactory screening of Parkinson’s Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin’ Sticks 12-identification test” (PLoS one (2019); 14 (11): e0224331 (1-12))
  8. J. Zimmermann, S. Jesse, J. Kassubek, E. Pinkhardt, A. C. Ludolph: „Differential diagnosis of peripheral facial nerve palsy – a retrospective clinical, MRI and CSF-based study”(Journal of Neurology (2019); 266 (10): 2488-2494)
  9. H.-P. Müller, D. Brenner, F. Roselli, D. Wiesner, A. Abaei, M. Gorges, K. M. Danzer, A. C. Ludolph, W. Tsao, P. C. Wong, V. Rasche, J. H. Weishaupt, J. Kassubek: “Longitudinal diffusion tensor magnetic resonance imaging analysis at the cohort level reveals disturbed cortical and callosal microstructure with spared corticospinal tract in the TDP-43G298S ALS mouse model” (Translational Neurodegeneration (2019); 8: 27 (1-13))
  10. V. Grozdanov, L. Bousset, M. Hoffmeister, C. Bliederhaeuser, C. Meier, K. Madiona, L. Pieri, M. Kiechle, P. J. McLean, J. Kassubek, C. Behrends, A. C. Ludolph, J. H. Weishaupt, R. Melki, K. M. Danzer:„Increased immune activation by pathologic alpha-synuclein in Parkinson's Disease”(Annals of Neurology (2019); 86 (4): 593-606)
  11. J. Kassubek, M. Pagani:  “Imaging in amyotrophic lateral sclerosis - MRI and PET” (Current Opinion in Neurology (2019); 32 (5): 740-746) 
  12. H.-P. Müller, H.-J. Huppertz, J. Dreyhaupt, A. C. Ludolph, S. J. Tabrizi, R. A. C. Roos, A. Durr, G. B. Landwehrmeyer, J. Kassubek: „Combined cerebral atrophy score in Huntington´s disease based on atlas-based MRI volumetry: sample size calculations for clinical trials” (Parkinsonism and Related Disorders (2019); 63: 179-184)
  13. M.-J. Grimm, G. Respondek, M. Stamelou, T. Arzberger, L. Ferguson, E. Gelpi, A. Giese, M. Grossman, D. J. Irwin, A. Pantelyat, A. Rajput, S. Roeber, J. C van Swieten, C. Troakes, A. Antonini, K. P .Bhatia, C. Colosimo, T. van Eimeren, J. Kassubek, J. Levin, W. G Meissner, C. Nilsson, W. H Oertel, I. Piot, W. Poewe, G. K. Wenning, A. Boxer, L. I. Golbe, K. A. Josephs, I. Litvan, H. R. Morris, J. L. Whitwell, Y. Compta, J.-C. Corvol, A. E Lang, J. B. Rowe, G. U. Höglinger, for the Movement Disorder Society-endorsed PSP Study Group: “How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy” (Movement Disorders (2019); 34 (8): 1228-1232)                                           
  14. F. Albrecht, K. Mueller, T. Ballarini, L. Lampe, J. Diehl-Schmid, K. Fassbender, K. Fliessbach, H. Jahn, J. Kassubek, J. Kornhuber, M. Lauer, J. Prudlo, A. Schneider, M. Synofzik, J. Wiltfang, R. Jech, M. Otto; FTLD-Consortium; M. L. Schroeter:„Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging” (Cortex (2019); 117: 33-40)
  15. J. Levin, S. Maaß, M. Schuberth, A. Giese, W. H. Oertel, W. Poewe, C. Trenkwalder, G. K. Wenning, U. Mansmann, M. Südmeyer, K. Eggert, B. Mollenhauer, A. Lipp, M. Löhle, J. Classen, A. Münchau, J. Kassubek, F. Gandor, D. Berg, S. Egert-Schwender, C. Eberhardt, F. Paul, K. Bötzel, B. Ertl-Wagner, H. J. Huppertz, I. Ricard, G. U. Höglinger; PROMESA Study Group: “Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial” (Lancet Neurology (2019); 18 (8): 724-735)
  16. W. H. Jost, P. Lingor, L. Tönges, J. Schwarz, C. Buhmann, J. Kassubek, A. Schrag:„Dyskinesia in Multiple System Atrophy and Progressive Supranuclear Palsy”(Journal of Neural Transmission (2019); 126 (7): 925-932)
  17. M. Gorges, H.-P. Müller, I. Liepelt-Scarfone, A. Storch, R. Dodel, LANDSCAPE Consortium, R. Hilker-Roggendorf, D. Berg, M. S. Kunz, E. Kalbe, S. Baudrexel, J. Kassubek: “Structural brain signature of cognitive decline in Parkinson’s disease: DTI-based evidence from the LANDSCAPE study” (Therapeutic Advances in Neurological Disorders (2019); 12: 1756286419843447 (1-15)
  18. J. Dorst, L. Chen, A. Rosenbohm, J. Dreyhaupt, A. Hübers, J. Schuster, J. Weishaupt, J. Kassubek, B. Gess, T. Meyer, U. Weyen, A. Hermann,  J. Winkler, T. Grehl, T. Hagenacker, P. Lingor, J. C. Koch, A. Emmer, S. Petri, J. Großkreutz, M. Metelmann, J. Wolf, A. S. Winkler, T. Klopstock, M. Boentert, S. Johannesen, A. Storch, B. Schrank, D. Zeller, X. L. Liu, L. Tang, D. S. Fan, A. C. Ludolph: “Prognostic factors in ALS: A comparison between Germany and China” (Journal of Neurology (2019); 266 (6): 1516-1525)
  19. M. P. van den Heuvel, L. H. Scholtens, H. K. van der Burgh, F. Agosta, C. Alloza, C. Arango, B. Auyeung, S. Baron-Cohen, S. Basaia, M. J. N. L. Benders, F. Beyer, L. Booij, K. P. J. Braun, G. B. Filho, W. Cahn, D.M. Cannon, T. M. Chaim-Avancini, S.S. M. Chan, E. Y. H. Chen, B. Crespo-Facorro, E. A. Crone, U. Dannlowski, S. M. C. de Zwarte, B. Dietsche, G. Donohoe, S. Du Plessis, S. Durston, C. M. Díaz-Caneja, A. M. Díaz-Zuluaga, R. Emsley, M. Filippi, T. Frodl, M. Gorges, B. Graff, D. Grotegerd, D. Garsecki, J. M. Hall, L. Holleran, R. Holt,  H.J. Hopman,  A. Jansen, J. Janssen, K. Jodzio, L. Jäncke, V. G. Kaleda, J. Kassubek, S. K. Masouleh, T. Kircher, M. G. J. C. Koevoets, V. S. Kostic, A. Krug, S. M. Lawrie, I. S. Lebedeva, E. H. M. Lee, T. A. Lett, S. J. G. Lewis, F. Liem, M. V. Lombardo, C. Lopez-Jaramillo, D. S. Margulies, S. Markett, P. Marques, I. Martínez-Zalacaín, C. McDonald, A. M. McIntosh, G. McPhilemy, S. L. Meinert, J. M. Menchón, C. Montag, P. S. Moreira, P. Morgado, D. O. Mothersill, S. Mérillat, H.-P. Müller, L. Nabulsi, P. Najt, K. Narkiewicz, P. Naumczyk, B. Oranje, V. Ortiz-Garcia de la Foz, J. S. Peper, J. A. Pineda, P. E. Rasser, R. Redlich, J. Repple, M. Reuter, P. G. P. Rosa, A. N. V. Ruigrok, A. Sabisz, U. Schall, S. Seedat, M. H. Serpa, S. Skouras, C. Soriano-Mas, N. Sousa, E. Szurowska, A. S. Tomyshev, D. Tordesillas-Gutierrez, S. L. Valk, L. H. van den Berg, T. G. M. van Erp, N. E. M. van Haren, J. M. C. van Leeuwen, A. Villringer, C. C. H. Vinkers, C. Vollmar, L. Waller, H. Walter, H. C. Whalley, M. Witkowska, A. V. Witte, M. V. Zanetti, R. Zhang, S.C. de Lange:“10Kin1day: a bottom-up neuroimaging initiative” (Frontiers in Neurology (2019); 10: 425 (1-7))
  20. R. di Giuseppe, S. Plachta-Danielzik, M. Koch, U. Nöthlings, S. Schlesinger, J. Borggrefe, M. Both, H.-P. Müller, J. Kassubek, G. Jacobs, W. Lieb: „Dietary pattern associated with selenoprotein P and MRI-derived body fat volumes, liver signal intensity, and metabolic disorders” (European Journal of Nutrition (2019); 58 (3): 1067-1079)                          
  21. C. Brittain, A. McCarthy, M. C. Irizarry, D. McDermott, K. Biglan, G. U. Höglinger, S. Lorenzl, T. Del Ser, A. L. Boxer; AL-108-231 Study Group; PROPSPERA investigators; 4RNTI-1authors; Tau Restoration on PSP (TAUROS) Investigators [incl. J. Kassubek]: “Severity dependent distribution of impairments in PSP and CBS: interactive visualizations” (Parkinsonism and Related Disorders (2019); 60: 138-145)
  22. S. Stösser, S. Böckler, A. C. Ludolph, J. Kassubek, H. Neugebauer: „Juxtacortical lesions are associated with seizures in cerebral small vessel disease” (Journal of Neurology (2019); 266 (5): 1230-1235)
  23. F. Hopfner, S. H. Müller, D. Steppat, J. Miller, N. Schmidt, K.-P. Wandinger, F. Leypoldt, D. Berg, A. Franke, W. Lieb, L. Tittmann, M. Balzer-Geldsetzer, S. Baudrexel, R. Dodel, R. Hilker-Roggendorf, E. Kalbe, J. Kassubek, T. Klockgether, I. Liepelt-Scarfone, B. Mollenhauer, P. Neuser, K. Reetz, O. Riedel, C. Schulte, J. B. Schulz, A. Spottke, A. Storch, C. Trenkwalder, H.-U. Wittchen, K. Witt, U. Wüllner, G. Deuschl, G. Kuhlenbäumer: “No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors” (Translational Neurodegeneration (2019); 8: 11 (1-7))
  24. H.-P. Müller, J. Kassubek: “Editorial: Computerized magnetic resonance imaging-based neuroimaging of neurodegenerative diseases” (Frontiers in Neurology (2019); 10: 237 (1-2))
  25. M. Schoen, H. Asoglu, H. F. Bauer, H.-P. Müller, A. Abaei, A. K. Sauer, R. Zhang, T. Song, J. Bockmann, J. Kassubek, V. Rasche, A. M. Grabrucker, T. M. Boeckers:„Shank3 transgenic and prenatal zinc-deficient autism mouse models show convergent and individual alterations of brain structures in MRI” (Frontiers in Neural Circuits (2019); 13: 6 (1-11))
  26. F. Schradt, S. Stösser, M. Hänle, J. Kassubek, B. Lindner-Pfleghar, H. Neugebauer: “Botulinumtoxin bei neurogener Dysphagie nach Hirnstammischämie” (Nervenarzt (2019); 90 (2): 191-193)
  27. S. Schönecker, F. Hell, K. Bötzel, E. Wlasich, N. Ackl, C. Süßmair; German FTLD Consortium, M. Otto, S. Anderl-Straub, A. Ludolph, J. Kassubek, H. J. Huppertz, J. Diehl-Schmid, L. Riedl, C. Roßmeier, K. Fassbender, E. Lyros, J. Kornhuber, T. J. Oberstein, K. Fliessbach, A. Schneider, M. L. Schroeter, J. Prudlo, M. Lauer, H. Jahn, J. Levin, A. Danek: “The applause sign in frontotemporal lobar degeneration and related conditions” (Journal of Neurology (2019); 266 (2): 330-338)
  28. J. Diehl-Schmid, A. Licata, O. Goldhardt, H. Förstl, I. Yakushew, M. Otto, S. Anderl-Straub, A. Beer, A. C. Ludolph, G. B. Landwehrmeyer, J. Levin, A. Danek, K. Fliessbach, A. Spottke, K. Fassbender, E. Lyros, J. Prudlo, B. J. Krause, A. E.  Volk, D. Edbauer, M. L. Schroeter, A. Drzezga, J. Kornhuber, M. Lauer; FTLDc Study Group [incl. J. Kassubek], T. Grimmer: “FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations (Translational Psychiatry (2019); 9 (1): 54 (1-11))
  29. Y. Forouhideh, K. Müller, W. Ruf, A. Knehr, M. Assi, T. M. Strom, M. Gorges, F. Schradt, T. Meitinger, A. C. Ludolph, E. Pinkhardt, J. Kassubek, I. Uttner, J. H. Weishaupt: “A bi-allelic mutation links MYORG to autosomal-recessive primary familial brain calcification” (Brain (2019); 142 (2): e4 (1-4))
  30. D. Brenner, K. Müller, R. Gastl, M. Gorges, M. Otto, E. H. Pinkhardt, J. Kassubek, J. H. Weishaupt, A. C. Ludolph: „Analysis of CACNA1A CAG repeat lengths in patients with familial ALS“ (Neurobiology of Aging (2019); 74: 235.e5-235.e8)
  31. F. Verde, P. Steinacker, J. H. Weishaupt, J. Kassubek, P. Oeckl, S. Halbgebauer, H. Tumani, C. A. F. von Arnim, J. Dorst, E. Feneberg, B. Mayer, H.-P. Müller, M. Gorges, A. Rosenbohm, A. E. Volk, V. Silani, A. C. Ludolph, M. Otto:„ Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis” (Journal of Neurology, Neurosurgery, and Psychiatry (2019); 90 (2): 157-164)
  32. S. Jesse, J. Wagner, R. Gastl, P. Steinacker, M. Otto, J. Kassubek, J. Lewerenz: "On razor’s edge: managing analgosedation during severe anti-NMDA receptor encephalitis” (Neurology: Neuroimmunology & Neuroinflammation (2019); 6 (1): e522 (1-3))
  1. H. Braak, S. Feldengut, J. Kassubek, D. Yilmazer-Hanke, K. Del Tredici: "Two histological methods for recognition and study of cortical microinfarcts in thick sections”  (European Journal of Histochemistry (2018); 62 (4): 2989 (1-5)).
  2. K. M. E. Forsberg, Y. Zhang, J. Reiners, M. Ander, A. Niedermayer, L. Fang, H. Neugebauer, J. Kassubek, I. Katona, J. Weis, A. C. Ludolph, K. Del Tredici, H. Braak, D. Yilmazer-Hanke: „Endothelial Damage, Vascular Bagging and Remodeling of the Microvascular Bed in Human Microangiopathy with Deep White Matter Lesions” (Acta Neuropathologica Communications (2018); 6 (1): 128 (1-17)).
  3. M. Balzer-Geldsetzer, J. Klotsche, LANDSCAPE Consortium [incl. J. Kassubek], R. Dodel, O. Riedel: „Quality of life in a German cohort of Parkinson's patients assessed with three different measures” (Journal of Neurology (2018); 265 (11): 2713–2722).
  4. H.-P. Müller, F. Agosta, M. Gorges, R. Kassubek, E. G. Spinelli, N. Riva, A. C. Ludolph, M. Filippi, J. Kassubek: "Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: a two-center tract of interest-based DTI analysis" (Neuroimage Clinical (2018); 20: 1062-1069).
  5. M. Gorges, K. Del Tredici, J. Dreyhaupt, H. Braak, A. C. Ludolph, H.-P. Müller, J. Kassubek: „Corticoefferent pathology distribution in amyotrophic lateral sclerosis: in vivo evidence from a meta-analysis of diffusion tensor imaging data” (Scientific Reports (2018); 8 (1): 15389 (1-10)).
  6. J. Kassubek: “Idiopathisches Parkinsonsyndrom” (Klinikarzt (2018); 47: 450-454).
  7. P. Steinacker, S. Anderl-Straub, J. Diehl-Schmid, E. Semler, I. Uttner, C. A. F. von Arnim, H. Barthel, A. Danek, K. Fassbender, K. Fliessbach, H. Foerstl, T. Grimmer, H.-J. Huppertz, H. Jahn, J. Kassubek, J. Kornhuber, B. Landwehrmeyer, M. Lauer, J. M. Maler, B. Mayer, P. Oeckl, J. Prudlo, A. Schneider, A. E. Volk, J. Wiltfang, M. L. Schroeter, A. C. Ludolph, M. Otto, on behalf of the FTLDc study group: „Serum neurofilament light chain in behavioral variant frontotemporal dementia” (Neurology (2018); 91 (15): e1390-e1401).
  8. D. Brenner, R. Yilmaz, K. Müller, T. Grehl, S. Petri, T. Meyer, J. Grosskreutz, P. Weydt, W. Ruf, C. Neuwirth, M. Weber, S. Pinto, K.G. Claeys, B. Schrank, B. Jordan, A. Knehr, K. Günther, A. Hübers, D. Zeller; German ALS Network MND-NET [incl. J. Kassubek], C. Kubisch, S. Jablonka, M. Sendtner, T. Klopstock, M. de Carvalho, A. Sperfeld, G. Borck, A.E. Volk, J. Dorst, J. Weis, M. Otto, J. Schuster, K. Del Tredici, H. Braak, K.M. Danzer, A. Freischmidt, T. Meitinger, T. M. Strom, A. C. Ludolph, P. M. Andersen, J. H. Weishaupt: „Hot-spot KIF5A mutations cause familial ALS” (Brain (2018); 141 (3): 688-697).
  9. A. Abdelhak, A. Huss, J. Kassubek, H. Tumani, M. Otto: "Serum GFAP as a biomarker for disease severity in multiple sclerosis” (Scientific Reports (2018); 8 (1): 14798 (1-7)).
  10. H.-P. Müller, J. Kassubek: “MRI-based mapping of cerebral propagation in amyotrophic lateral sclerosis“ (Frontiers in Neuroscience (2018); 12: 655 (1-7)).
  11. Buhmann, C. W. Ip, C. Oehlwein, L. Tönges, M. Wolz, H. Reichmann, J. Kassubek: „Das idiopathische Parkinsonsyndrom und Schmerz – diagnostische und therapeutische Ansätze für ein herausforderndes nicht-motorisches Symptom“ (Fortschritte der Neurologie – Psychiatrie (2018); 86 (S 01): S48-S58).
  12. W. Becker, J. Kassubek, C. Maurer, T. Mergner: „Targeting head movements in humans: Compensation for disturbance from simultaneous body rotations“ (Human Movement Science (2018); 61: 197-218)
  13. B. Commisso, L. Ding, K. Varadi, M. Gorges, D. Bayer, T. M. Boeckers, A. C. Ludolph, J. Kassubek, O. Mueller, F. Roselli: „Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9“ (eLife (2018); 7: e36892)
  14. A. Hübers, K. Thoma, M. Schocke, S. Fauser, A. C. Ludolph, J. Kassubek, E. H. Pinkhardt: „Acute DWI restrictions in patients after single epileptic seizures - more common than assumed” (Frontiers in Neurology (2018); 9: 550 (1-7)).
  15. C. Schönfeldt-Lecuona, A. Schmidt, T. Kregel, J. Kassubek, J. Dreyhaupt, R. W. Freudenmann, B. J. Connemann, E. H. Pinkhardt, M. Gahr: „Response letter: Retinal changes in patients with major depressive disorder – a controlled optical coherence tomography study” (Journal of Affective Disorders (2018); 239: 123)                                             
  16. A. C. Ludolph, J. Schuster, J. Dorst, L. Dupuis, J. Dreyhaupt, J. H. Weishaupt, J. Kassubek, U. Weiland, S. Petri, T. Meyer, J. Grosskreutz, B. Schrank, M. Boentert, A. Emmer, A. Hermann, D. Zeller, J. Prudlo, A. S. Winkler, T. Grehl, M. T. Heneka, S. Wollebæk Johannesen, B. Göricke; RAS-ALS Study Group: “Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with myotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial” (Lancet Neurology (2018); 17 (8): 681-688)
  17. K. Müller, D. Brenner, P. Weydt, T. Meyer, T. Grehl, S. Petri, J. Grosskreutz, J. Schuster, A. E. Volk, G. Borck, C. Kubisch, T. Klopstock, D. Zeller, S. Jablonka, M. Sendtner, S. Klebe, A. Knehr, K. Günther, J. Weis, K. G. Claeys, B. Schrank, A. D. Sperfeld, A. Hübers, M. Otto, J. Dorst, T. Meitinger, T. M. Strom, P. M.  Andersen, A. C. Ludolph, J. H. Weishaupt; German ALS Network MND-NET [incl. J. Kassubek]: “Comprehensive analysis of the mutation spectrum in 301 German ALS families“ (Journal of Neurology, Neurosurgery, and Psychiatry (2018); 89 (8): 817-827).
  18. J. Kassubek: “MRI-based neuroimaging: atypical parkinsonisms and other movement disorders” (Current Opinion in Neurology (2018); 31 (4): 425-430).
  19. R. L. Barlow, M. Gorges, A. Wearn, H. G. Niessen, J. Kassubek, J. W. Dalley, A. Pekcec: “Altered ventral striatal D2/3 receptor availability is associated with impulsive choice behavior and abnormalities in limbic corticostriatal connectivity” (International Journal of Neuropsychopharmacology (2018); 21 (7): 705-715)
  20. J. Keller, S. Böhm, H. E. Aho-Özhan, M. Gorges, J. Kassubek, I. Uttner, S. Abrahams, A. C. Ludolph, D. Lulé: “Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis” (Brain Imaging and Behavior (2018); 12 (3): 771-784)
  21. S. Schmid, E. Goldberg-Bockhorn, S. Schwarz, N. Rotter, J. Kassubek, K. Del Tredici, E. Pinkhardt, M. Otto, A. C. Ludolph, P. Oeckl: “Alpha-synuclein is present in dental calculus but not altered in Parkinson´s disease patients in comparison to controls” (Journal of Neurology (2018); 265 (6): 1334-1337)
  22. M. Gorges, H.-P. Müller, J. Kassubek: “Structural and functional brain mapping correlates of impaired eye movement control in parkinsonian syndromes: a systems-based concept” (Frontiers in Neurology (2018); 9: 319 (1-10)).
  23. A. Rosenbohm, S. Hirsch, A. E. Volk, T. Grehl, J. Grosskreutz, F. Hanisch,  A. Herrmann, K. Kollewe, W. Kress, T. Meyer, S. Petri, J. Prudlo, C. Wessig, H.-P. Müller, J. Dreyhaupt, J. Weishaupt, C. Kubisch, J. Kassubek, P. Weydt, A. Ludolph: „The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy” (Journal of Neurology (2018); 265 (5): 1026-1036)
  24. A. Abdelhak, A. Hübers, K. Böhm, A. C. Ludolph, J. Kassubek, E. Pinkhardt: “In vivo measurement of retinal vessel pathology in amyotrophic lateral sclerosis” (Journal of Neurology (2018); 265 (4): 949-953)
  25. A. Rosenbohm, M. Liu, G. Nagel, R. S. Peter, B. Cui, X. Li, J. Kassubek, D. Rothenbacher, D. Lulé, L. Cui, A. C. Ludolph, for the ALS Registry Swabia Study Group: “Phenotypic differences of Amyotrophic Lateral Sclerosis (ALS) in China and Germany” (Journal of Neurology (2018); 265 (4): 774-782)
  26. S. Schönecker, C. Neuhofer, M. Otto, A. Ludolph, J. Kassubek, B. Landwehrmeyer, S. Anderl-Straub, E. Semler, J. Diehl-Schmid, C. Prix, C. Vollmar, J. Fortea, Deutsches FTLD-Konsortium, H.-J. Huppertz, T. Arzberger, D. Edbauer, B. Feddersen, M. Dieterich, M. L. Schröter, A. E. Volk, K. Fließbach, A. Schneider, J. Kornhuber, M. Maler, J. Prudlo, H. Jahn, T. Boeckh-Behrens, A. Danek, T. Klopstock, J. Levin: “Atrophy in the thalamus but not cerebellum is specific for C9orf72 FTD and ALS patients – an atlas-based volumetric MRI study” (Frontiers in Aging Neuroscience (2018); 10: 45 (1-11))
  27. H.-P. Müller, M. Gorges, R. Kassubek, J. Dorst, A.C. Ludolph, J. Kassubek: "Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: a tract of interest-based MRI study" (Neuroimage Clinical (2018); 18: 762-769).
  28. J. Kassubek, H. P. Müller, K. Del Tredici, D. Lulé, M. Gorges, H. Braak, A. C. Ludolph: "Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker" (Journal of Neurology, Neurosurgery, and Psychiatry (2018); 89 (4): 374-381)
  29. D. Lulé, S. Böhm, H.-P. Müller, H. Aho-Özhan, J. Keller, M. Gorges, M. Loose, J. Weishaupt, I. Uttner, E. Pinkhardt, J. Kassubek, K. Del Tredici, H. Braak, S. Abrahams, A. C Ludolph: "Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis" (Cortex (2018); 101: 163-171)
  30. J. Rosskopf, M. Gorges, H.-P. Müller, E. H. Pinkhardt, A. C. Ludolph, J. Kassubek:"Hyperconnective and hypoconnective cortical and subcortical functional networks in multiple system atrophy" (Parkinsonism and Related Disorders (2018); 49: 75-80).
  31. J. Kassubek, H.-P. Müller, K. Del Tredici, M. Hornberger, M. L. Schroeter, K. Müller, S. Anderl-Straub, I. Uttner, M. Grossman, H. Braak, J. R. Hodges, O. Piguet, M. Otto, A. C. Ludolph: "Longitudinal diffusion tensor imaging resembles patterns of pathology progression in behavioral variant frontotemporal dementia (bvFTD)" (Frontiers in Aging Neuroscience (2018); 10: 47 (1-13))
  32. P. Steinacker, F. Verde, L. Fang, E. Feneberg, P. Oeckl, S. Roeber, S. Anderl-Straub, A. Danek, J. Diehl-Schmid, K. Fassbender K. Fliessbach, H. Foerstl, FTLDc study group, A. Giese, H. Jahn, J. Kassubek, J. Kornhuber, B. Landwehrmeyer, M. Lauer, E. Pinkhardt, J. Prudlo, A. Rosenbohm, A. Schneider, M. L. Schroeter, H. Tumani, C. A. F. von Arnim, J. Weishaupt, P. Weydt, A. C. Ludolph, D. Yilmazer-Hanke, M. Otto: “Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression” (Journal of Neurology, Neurosurgery and Psychiatry (2018); 89 (3): 239-247).
  33. H.-P. Müller, F. Agosta, N. Riva, E. G. Spinelli, G. Comi, A. C. Ludolph, M. Filippi, J. Kassubek: "Fast progressive lower motor neuron disease is an ALS variant: a two-centre tract of interest-based MRI data analysis" (Neuroimage Clinical (2018); 17: 145-152)
  34. C. Schönfeldt-Lecuona, A. Schmidt, T. Kregel, J. Kassubek, J. Dreyhaupt, R. W. Freudenmann, B. J. Connemann, E. H. Pinkhardt, M. Gahr: „Retinal changes in patients with major depressive disorder - a controlled optical coherence tomography study” (Journal of Affective Disorders (2018); 227: 665-671)
  1. M. Gorges, P. Vercruysse, H.-P. Müller, H.-J. Huppertz, A. Rosenbohm, G. Nagel, P. Weydt, Å. Petersén, A. C. Ludolph, J. Kassubek*, L. Dupuis* (*shared senior authorship): “Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis” (Journal of Neurology, Neurosurgery and Psychiatry (2017); 88 (12): 1033-1041)
  2. D. Baldaranov, A. Khomenko, I. Kobor, U. Bogdahn, M. Gorges, J. Kassubek, H. P. Müller: „Longitudinal diffusion tensor imaging-based assessment of tract alterations: an application to amyotrophic lateral sclerosis” (Frontiers in Human Neuroscience (2017); 11: 567 (1-8))
  3. A. Antonini, W. Poewe, K. R. Chaudhuri, R. Jech, B. Pickut, Z. Pirtošek, J. Szasz, F. Valldeoriola, C. Winkler, L. Bergmann, A. Yegin, K. Onuk, D. Barch, P. Odin; GLORIA study co-investigators [including J. Kassubek]: “Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry” (Parkinsonism and Related Disorders (2017); 45: 13-20)
  4. R. S. Peter, A. Rosenbohm, L. Dupuis, T. Brehme, J. Kassubek, D. Rothenbacher, G. Nagel, A. C. Ludolph: „Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis - results from the ALS registry Swabia” (European Journal of Epidemiology (2017); 32 (10): 901-908)
  5. S. Waniek, R. di Giuseppe, S. Plachta-Danielzik, I. Ratjen, G. Jacobs, M. Koch, J. Borggrefe, M. Both, H.-P. Müller, J. Kassubek, U. Nöthlings, T. Esatbeyoglu, S. Schlesinger, G. Rimbach, W. Lieb: “Association of vitamin E levels with metabolic syndrome, MRI-derived body fat volumes and liver fat content” (Nutrients (2017); 9 (10): 1143 (1-15))
  6. R. Di Giuseppe, M. Koch, S. Schlesinger, J. Borggrefe, M. Both, H.-P. Müller, J. Kassubek, G. Jacobs, U. Nöthlings, W. Lieb: „Cross-sectional associations of selenoprotein P with MRI-derived body fat volumes, liver fat content, and metabolic disorders in the general population” (Atherosclerosis (2017); 263: e160)
  7. A. Rosenbohm, B. Schmid, D. Buckert, W. Rottbauer, J. Kassubek, A. C. Ludolph, P. Bernhardt: „Cardiac findings in amyotrophic lateral sclerosis: a magnetic resonance imaging study” (Frontiers in Neurology (2017); 8: 479 (1-8))
  8. M. Gorges, M. N. Maier, J. Rosskopf, O. Vintonyak, E. H. Pinkhardt, A. C. Ludolph, H.-P. Müller, J. Kassubek: „Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes” (Journal of Neurology (2017); 264 (9): 1919–1928)
  9. R. Kassubek, M. Gorges, M. Schocke, V. A. M. Hagenston, A. Huss, A. C. Ludolph, J. Kassubek, H. Tumani: "GFAP in early multiple sclerosis: a biomarker for inflammation” (Neuroscience Letters (2017); 657: 166-170)
  10. J. Kassubek, H.-J. Huppertz, G. U. Höglinger: „Reply to: MRI measures of brainstem in parkinsonian syndromes: Where we stand and where we need to go” (Movement Disorders (2017); 32 (8): 1261-1262)
  11. G. U. Höglinger, J. Kassubek, I. Csoti, R. Ehret, H. Herbst, I. Wellach, J. Winkler, W. H. Jost: “Differentiation of atypical Parkinson syndromes” (Journal of Neural Transmission (2017); 124 (8): 997-1004)
  12. J. Rosskopf, M. Gorges, H. P. Müller, D. Lulé, I. Uttner, A. C. Ludolph, E. H. Pinkhardt, F. D. Juengling, J. Kassubek: “Intrinsic functional connectivity alterations in Progressive Supranuclear Palsy: differential effects in frontal cortex, motor and midbrain networks” (Movement Disorders (2017); 32 (7): 1006-1015)
  13. G. Respondek, C. Kurz, T. Arzberger, Y. Compta, E. Englund, L. W. Ferguson, E. Gelpi, A. Giese, D. J. Irwin, W. G. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, J. C. van Swieten, C. Troakes, K. A. Josephs, A. E. Lang, B. Mollenhauer,  U. Müller, J. L. Whitwell, A. Antonini, K. P. Bhatia, Y. Bordelon, J. C. Corvol, C. Colosimo, R. Dodel, M. Grossman, MD, J. Kassubek, F. Krismer, J. Levin, S. Lorenzl, H. Morris, P. Nestor, W. H. Oertel, G. D. Rabinovici, J. R. Rowe, T. van Eimeren, G. K Wenning, A. Boxer, L. I. Golbe, I. Litvan, M. Stamelou, G. U. Höglinger, the Movement Disorder Society-endorsed PSP Study Group: “Which ante-mortem clinical features predict progressive supranuclear palsy pathology?” (Movement Disorders (2017); 32 (7): 995-1005)    
  14. J. L. Whitwell, G. U. Höglinger, A. Antonini, Y. Bordelon, A. L. Boxer, C. Colosimo, T. van Eimeren, L. I. Golbe, J. Kassubek, C. Kurz, I. Litvan, A. Pantelyat, G. Rabinovici, G. Respondek, A. Rominger, J. B. Rowe, M. Stamelou, K. A. Josephs, the Movement Disorder Society-endorsed PSP Study Group: “Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be?” (Movement Disorders (2017); 32 (7): 955-971)
  15. R. Kassubek, M. Gorges, M.-A. Westhoff, A. C. Ludolph, J. Kassubek, H.-P. Müller: "Cerebral microstructure alterations after radiation therapy in high-grade glioma: a diffusion tensor imaging-based study" (Frontiers in Neurology (2017);8: 286 (1-8))
  16. J. Keller, A. Krimly, L. Bauer, S. Schulenburg, S. Böhm, H. E. A. Aho-Özhan, I. Uttner, M. Gorges, J. Kassubek, E. H. Pinkhardt, S. Abrahams, A. C. Ludolph, D. Lulé: “A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS screen” (Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2017); 18 (5-6): 443-450)
  17. G. U. Höglinger, J. Schöpe, M. Stamelou, J. Kassubek, T. del Ser, A. L. Boxer, S. Wagenpfeil, H.-J. Huppertz: "Longitudinal MRI in progressive supranuclear palsy: a new combined score for clinical trials” (Movement Disorders (2017); 32 (6): 842-852)
  18. G. U. Höglinger, G. Respondek, M. Stamelou, C. Kurz, K. A. Josephs, A. E Lang, B. Mollenhauer, U. Müller, C. Nilsson, J. L. Whitwell, T. Arzberger, E. Englund,  E. Gelpi, A. Giese, D. J. Irwin, W. G. Meissner, A. Pantelyat, A. Rajput, J. C. van Swieten, C. Troakes, A. Antonini, K. P. Bhatia, Y. Bordelon, Y. Compta, J.-C. Corvol, C. Colosimo, D. W. Dickson, R. Dodel, L. Ferguson, M. Grossman, J. Kassubek, F. Krismer, J. Levin, S. Lorenzl, H. R. Morris, P. Nestor, W. H. Oertel, W. Poewe, G. Rabinovici, J. B. Rowe, G. D. Schellenberg, K. Seppi, T. van Eimeren, G. K. Wenning, A. Boxer, L. I. Golbe, I. Litvan for the Movement Disorder Society-endorsed PSP Study Group: “Clinical diagnosis of progressive supranuclear palsy - the Movement Disorder Society criteria” (Movement Disorders (2017); 32 (6): 853-864)
  19. R. di Giuseppe, S. Plachta-Danielzik, M. Koch, U. Nöthlings, S. Schlesinger, J. Borggrefe, M. Both, H.-P. Müller, J. Kassubek, G. Jacobs, W. Lieb: “Circulating selenoprotein P levels in relation to MRI-derived body fat volumes, liver fat content, and metabolic disorders” (Obesity (2017); 5 (6): 1128-1135)
  20. M. Gorges, F. Roselli, H.-P. Müller, A. C. Ludolph, V. Rasche, J. Kassubek: „Functional connectivity mapping in the animal model: principles and applications of resting-state fMRI” (Frontiers in Neurology (2017); 8: 200 (1-14))
  21. L. Möller, J. Kassubek, M. Südmeyer, R. Hilker, E. Hattingen, K. Egger, F. Amtage, E. H. Pinkhardt, G. Respondek, M. Stamelou, A. Schnitzler, W. H. Oertel, S. Knake, H.-J. Huppertz, G. U. Höglinger: “Manual MRI morphometry in Parkinsonian syndromes” (Movement Disorders (2017); 32 (5): 778-782)
  22. V. Wais, A. Rosenbohm, S. Petri, K. Kollewe, A. Hermann, A. Storch, F. Hanisch, S. Zierz, G. Nagel, J. Kassubek, P. Weydt, J. Brettschneider, J. H. Weishaupt, A. C. Ludolph, J. Dorst: „The concept and diagnostic criteria of primary lateral sclerosis” (Acta Neurologica Scandinavica (2017); 136 (3): 204-211)
  23. R. Kassubek, I. Uttner, C. Schönfeldt-Lecuona, J. Kassubek, B. J. Connemann: “Extending the aceruloplasminemia phenotype: a case with NBIA on imaging and acanthocytosis, yet only minor neurological findings” (Journal of the Neurological Sciences (2017); 376: 151-152)
  24. P. Fissler, H.-P. Müller, O. C. Küster, D. Laptinskaya, F. Thurm, A. Woll, T. Elbert, J. Kassubek, C. A.F. von Arnim, I. T. Kolassa: “No evidence that short-term cognitive or physical training programs or lifestyles are related to changes in white matter integrity in older adults at risk of dementia” (Frontiers in Human Neuroscience (2017); 11: 110 (1-14))
  25. R. Kassubek, L. Bullinger, J. Kassubek, J. Dreyhaupt, A. C. Ludolph, K. Althaus, J. Lewerenz: “Identifying ischemic stroke associated with cancer – a multiple model derived from a case-control analysis” (Journal of Neurology (2017); 264 (4): 781-791)
  26. K. Mueller, R. Jech, C. Bonnet, J. Tintěra, J. Hanuška, H. E. Möller, K. Fassbender, A. Ludolph, J. Kassubek, M. Otto, E. Růžička, M. L. Schroeter, FTLDc study group: “Disease-specific regions outperform whole-brain approaches in identifying progressive supranuclear palsy: a multi-centric MRI study” (Frontiers in Neuroscience (2017); 11: 100 (1-11))
  27. S. Meyer, K. Mueller, K. Stuke, S. Bisenius, J. Diehl-Schmid, F. Jessen, J. Kassubek, J. Kornhuber, A. C. Ludolph, J. Prudlo, A. Schneider, K. Schuemberg, I. Yakushev, M. Otto, M. L. Schroeter, FTLDc Study Group: “Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI” (Neuroimage Clinical (2017); 14: 656-662)
  28. J. Kassubek: “The application of neuroimaging to healthy and diseased brains: present and future” (Frontiers in Neurology (2017); 8: 61 (1-2))
  29. O. Vintonyak, M. Gorges, H. P. Müller, E. H. Pinkhardt, A. C. Ludolph, H.-J. Huppertz, J. Kassubek: „Patterns of eye movement impairment correlate with regional brain atrophy in neurodegenerative parkinsonism“ (Neurodegenerative Diseases (2017); 17 (4-5): 117-126)
  30. B. Lieske, G. Röhrig, I. Becker, R. J. Schulz, M. C. Polidori, J. Kassubek: „Stationär behandelte geriatrische Patienten mit Eisenmangel-assoziiertem Restless Legs Syndrom: eine retrospektive Analyse“ (MMW - Fortschritte der Medizin (2017); 159 (4): 12-17)
  31. M. Gorges, H.-P. Müller, I. M. S. Mayer, G. S. Grupe, T. Kammer, G. Grön, J. Kassubek, G. B. Landwehrmeyer, R. C. Wolf, M. Orth: “Intact sensory-motor network structure and function in far from onset premanifest Huntington´s disease” (Scientific Reports (2017); 7: 43841 (1-9))                            
  32. P. Steinacker, E. Semler, S. Anderl-Straub, J. Diehl-Schmid, M. L. Schroeter, I. Uttner, B. Landwehrmeyer, C. A. F. von Arnim, J. Kassubek, P. Oeckl, H.-J. Huppertz, K. Fassbender, K. Fliessbach, J. Prudlo, J. Kornhuber, A. Schneider, A. Volk, M. Lauer, K. Fassbender, A. Danek, A. C. Ludolph, M. Otto: “Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias“ (Neurology (2017); 88 (10): 961-969)
  33. S. Bisenius, K. Mueller, J. Diehl-Schmid, K. Fassbender, T. Grimmer, F. Jessen, J. Kassubek, J. Kornhuber, B. Landwehrmeyer, A. Ludolph, A. Schneider, S. Anderl-Straub, K. Stuke, A. Danek, M. Otto, M. L. Schroeter, FTLDc study group: “Predicting primary progressive aphasias with support vector machine approaches in structural MRI data” (Neuroimage Clinical (2017); 14: 334-343)
  34. B. Lindner-Pfleghar, H. Neugebauer, S. Stösser, J. Kassubek, A. Ludolph, R. Dziewas, M. Prosiegel, A. Riecker: „Dysphagiemanagement beim akuten Schlaganfall: eine prospektive Studie zur Überprüfung der geltenden Empfehlungen“ (Nervenarzt (2017); 88 (2): 173-179)
  35. L. Timmermann, C. Oehlwein, G. Ransmayr, H. Fröhlich, E. Will, H. Schroeder, T. Lauterbach, L. Bauer, J. Kassubek: „Patients’ perception of Parkinson’s disease-associated pain following initiation of rotigotine: a multicenter non-interventional study” (Postgraduate Medicine (2017); 129 (1): 46-54)
  1. I. M. Gorges, P. Vercruysse, H.-P. Müller, H.-J. Huppertz, A. Rosenbohm, G. Nagel, P. Weydt, Å. Petersén, A. C. Ludolph, J. Kassubek*, L. Dupuis* (*shared senior authorship): “Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis” (Journal of Neurology, Neurosurgery and Psychiatry (2017); 88 (12): 1033-1041)
  2. D. Baldaranov, A. Khomenko, I. Kobor, U. Bogdahn, M. Gorges, J. Kassubek, H. P. Müller: „Longitudinal diffusion tensor imaging-based assessment of tract alterations: an application to amyotrophic lateral sclerosis” (Frontiers in Human Neuroscience (2017); 11: 567 (1-8))
  3. A. Antonini, W. Poewe, K. R. Chaudhuri, R. Jech, B. Pickut, Z. Pirtošek, J. Szasz, F. Valldeoriola, C. Winkler, L. Bergmann, A. Yegin, K. Onuk, D. Barch, P. Odin; GLORIA study co-investigators [including J. Kassubek]: “Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry” (Parkinsonism and Related Disorders (2017); 45: 13-20)
  4. R. S. Peter, A. Rosenbohm, L. Dupuis, T. Brehme, J. Kassubek, D. Rothenbacher, G. Nagel, A. C. Ludolph: „Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis - results from the ALS registry Swabia” (European Journal of Epidemiology (2017); 32 (10): 901-908)
  5. S. Waniek, R. di Giuseppe, S. Plachta-Danielzik, I. Ratjen, G. Jacobs, M. Koch, J. Borggrefe, M. Both, H.-P. Müller, J. Kassubek, U. Nöthlings, T. Esatbeyoglu, S. Schlesinger, G. Rimbach, W. Lieb: “Association of vitamin E levels with metabolic syndrome, MRI-derived body fat volumes and liver fat content” (Nutrients (2017); 9 (10): 1143 (1-15))
  6. A. Rosenbohm, B. Schmid, D. Buckert, W. Rottbauer, J. Kassubek, A. C. Ludolph, P. Bernhardt: „Cardiac findings in amyotrophic lateral sclerosis: a magnetic resonance imaging study” (Frontiers in Neurology (2017); 8: 479 (1-8))
  7. M. Gorges, M. N. Maier, J. Rosskopf, O. Vintonyak, E. H. Pinkhardt, A. C. Ludolph, H.-P. Müller, J. Kassubek: „Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes” (Journal of Neurology (2017); 264 (9): 1919–1928)
  8. R. Kassubek, M. Gorges, M. Schocke, V. A. M. Hagenston, A. Huss, A. C. Ludolph, J. Kassubek, H. Tumani: "GFAP in early multiple sclerosis: a biomarker for inflammation” (Neuroscience Letters (2017); 657: 166-170)
  9. J. Kassubek, H.-J. Huppertz, G. U. Höglinger: „Reply to: MRI measures of brainstem in parkinsonian syndromes: Where we stand and where we need to go” (Movement Disorders (2017); 32 (8): 1261-1262)
  10. G. U. Höglinger, J. Kassubek, I. Csoti, R. Ehret, H. Herbst, I. Wellach, J. Winkler, W. H. Jost: “Differentiation of atypical Parkinson syndromes” (Journal of Neural Transmission (2017); 124 (8): 997-1004)
  11. J. Rosskopf, M. Gorges, H. P. Müller, D. Lulé, I. Uttner, A. C. Ludolph, E. H. Pinkhardt, F. D. Juengling, J. Kassubek: “Intrinsic functional connectivity alterations in Progressive Supranuclear Palsy: differential effects in frontal cortex, motor and midbrain networks” (Movement Disorders (2017); 32 (7): 1006-1015)
  12. G. Respondek, C. Kurz, T. Arzberger, Y. Compta, E. Englund, L. W. Ferguson, E. Gelpi, A. Giese, D. J. Irwin, W. G. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, J. C. van Swieten, C. Troakes, K. A. Josephs, A. E. Lang, B. Mollenhauer,  U. Müller, J. L. Whitwell, A. Antonini, K. P. Bhatia, Y. Bordelon, J. C. Corvol, C. Colosimo, R. Dodel, M. Grossman, MD, J. Kassubek, F. Krismer, J. Levin, S. Lorenzl, H. Morris, P. Nestor, W. H. Oertel, G. D. Rabinovici, J. R. Rowe, T. van Eimeren, G. K Wenning, A. Boxer, L. I. Golbe, I. Litvan, M. Stamelou, G. U. Höglinger, the Movement Disorder Society-endorsed PSP Study Group: “Which ante-mortem clinical features predict progressive supranuclear palsy pathology?” (Movement Disorders (2017); 32 (7): 995-1005)   
  13. J. L. Whitwell, G. U. Höglinger, A. Antonini, Y. Bordelon, A. L. Boxer, C. Colosimo, T. van Eimeren, L. I. Golbe, J. Kassubek, C. Kurz, I. Litvan, A. Pantelyat, G. Rabinovici, G. Respondek, A. Rominger, J. B. Rowe, M. Stamelou, K. A. Josephs, the Movement Disorder Society-endorsed PSP Study Group: “Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be?” (Movement Disorders (2017); 32 (7): 955-971)
  14. R. Kassubek, M. Gorges, M.-A. Westhoff, A. C. Ludolph, J. Kassubek, H.-P. Müller: "Cerebral microstructure alterations after radiation therapy in high-grade glioma: a diffusion tensor imaging-based study" (Frontiers in Neurology (2017);8: 286 (1-8))
  15. J. Keller, A. Krimly, L. Bauer, S. Schulenburg, S. Böhm, H. E. A. Aho-Özhan, I. Uttner, M. Gorges, J. Kassubek, E. H. Pinkhardt, S. Abrahams, A. C. Ludolph, D. Lulé: “A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS screen” (Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2017); 18 (5-6): 443-450)
  16. G. U. Höglinger, J. Schöpe, M. Stamelou, J. Kassubek, T. del Ser, A. L. Boxer, S. Wagenpfeil, H.-J. Huppertz: "Longitudinal MRI in progressive supranuclear palsy: a new combined score for clinical trials” (Movement Disorders (2017); 32 (6): 842-852)
  17. G. U. Höglinger, G. Respondek, M. Stamelou, C. Kurz, K. A. Josephs, A. E Lang, B. Mollenhauer, U. Müller, C. Nilsson, J. L. Whitwell, T. Arzberger, E. Englund,  E. Gelpi, A. Giese, D. J. Irwin, W. G. Meissner, A. Pantelyat, A. Rajput, J. C. van Swieten, C. Troakes, A. Antonini, K. P. Bhatia, Y. Bordelon, Y. Compta, J.-C. Corvol, C. Colosimo, D. W. Dickson, R. Dodel, L. Ferguson, M. Grossman, J. Kassubek, F. Krismer, J. Levin, S. Lorenzl, H. R. Morris, P. Nestor, W. H. Oertel, W. Poewe, G. Rabinovici, J. B. Rowe, G. D. Schellenberg, K. Seppi, T. van Eimeren, G. K. Wenning, A. Boxer, L. I. Golbe, I. Litvan for the Movement Disorder Society-endorsed PSP Study Group: “Clinical diagnosis of progressive supranuclear palsy - the Movement Disorder Society criteria” (Movement Disorders (2017); 32 (6): 853-864)
  18. R. di Giuseppe, S. Plachta-Danielzik, M. Koch, U. Nöthlings, S. Schlesinger, J. Borggrefe, M. Both, H.-P. Müller, J. Kassubek, G. Jacobs, W. Lieb: “Circulating selenoprotein P levels in relation to MRI-derived body fat volumes, liver fat content, and metabolic disorders” (Obesity (2017); 5 (6): 1128-1135)
  19. M. Gorges, F. Roselli, H.-P. Müller, A. C. Ludolph, V. Rasche, J. Kassubek: „Functional connectivity mapping in the animal model: principles and applications of resting-state fMRI” (Frontiers in Neurology (2017); 8: 200 (1-14))
  20. L. Möller, J. Kassubek, M. Südmeyer, R. Hilker, E. Hattingen, K. Egger, F. Amtage, E. H. Pinkhardt, G. Respondek, M. Stamelou, A. Schnitzler, W. H. Oertel, S. Knake, H.-J. Huppertz, G. U. Höglinger: “Manual MRI morphometry in Parkinsonian syndromes” (Movement Disorders (2017); 32 (5): 778-782)
  21. V. Wais, A. Rosenbohm, S. Petri, K. Kollewe, A. Hermann, A. Storch, F. Hanisch, S. Zierz, G. Nagel, J. Kassubek, P. Weydt, J. Brettschneider, J. H. Weishaupt, A. C. Ludolph, J. Dorst: „The concept and diagnostic criteria of primary lateral sclerosis” (Acta Neurologica Scandinavica (2017); 136 (3): 204-211)
  22. R. Kassubek, I. Uttner, C. Schönfeldt-Lecuona, J. Kassubek, B. J. Connemann: “Extending the aceruloplasminemia phenotype: a case with NBIA on imaging and acanthocytosis, yet only minor neurological findings” (Journal of the Neurological Sciences (2017); 376: 151-152)
  23. P. Fissler, H.-P. Müller, O. C. Küster, D. Laptinskaya, F. Thurm, A. Woll, T. Elbert, J. Kassubek, C. A.F. von Arnim, I. T. Kolassa: “No evidence that short-term cognitive or physical training programs or lifestyles are related to changes in white matter integrity in older adults at risk of dementia” (Frontiers in Human Neuroscience (2017); 11: 110 (1-14))
  24. R. Kassubek, L. Bullinger, J. Kassubek, J. Dreyhaupt, A. C. Ludolph, K. Althaus, J. Lewerenz: “Identifying ischemic stroke associated with cancer – a multiple model derived from a case-control analysis” (Journal of Neurology (2017); 264 (4): 781-791)
  25. K. Mueller, R. Jech, C. Bonnet, J. Tintěra, J. Hanuška, H. E. Möller, K. Fassbender, A. Ludolph, J. Kassubek, M. Otto, E. Růžička, M. L. Schroeter, FTLDc study group: “Disease-specific regions outperform whole-brain approaches in identifying progressive supranuclear palsy: a multi-centric MRI study” (Frontiers in Neuroscience (2017); 11: 100 (1-11))
  26. S. Meyer, K. Mueller, K. Stuke, S. Bisenius, J. Diehl-Schmid, F. Jessen, J. Kassubek, J. Kornhuber, A. C. Ludolph, J. Prudlo, A. Schneider, K. Schuemberg, I. Yakushev, M. Otto, M. L. Schroeter, FTLDc Study Group: “Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI” (Neuroimage Clinical (2017); 14: 656-662)
  27. J. Kassubek: “The application of neuroimaging to healthy and diseased brains: present and future” (Frontiers in Neurology (2017); 8: 61 (1-2))
  28. O. Vintonyak, M. Gorges, H. P. Müller, E. H. Pinkhardt, A. C. Ludolph, H.-J. Huppertz, J. Kassubek: „Patterns of eye movement impairment correlate with regional brain atrophy in neurodegenerative parkinsonism“ (Neurodegenerative Diseases (2017); 17 (4-5): 117-126)
  29. B. Lieske, G. Röhrig, I. Becker, R. J. Schulz, M. C. Polidori, J. Kassubek: „Stationär behandelte geriatrische Patienten mit Eisenmangel-assoziiertem Restless Legs Syndrom: eine retrospektive Analyse“ (MMW - Fortschritte der Medizin (2017); 159 (4): 12-17)
  30. M. Gorges, H.-P. Müller, I. M. S. Mayer, G. S. Grupe, T. Kammer, G. Grön, J. Kassubek, G. B. Landwehrmeyer, R. C. Wolf, M. Orth: “Intact sensory-motor network structure and function in far from onset premanifest Huntington´s disease” (Scientific Reports (2017); 7: 43841 (1-9))                           
  31. P. Steinacker, E. Semler, S. Anderl-Straub, J. Diehl-Schmid, M. L. Schroeter, I. Uttner, B. Landwehrmeyer, C. A. F. von Arnim, J. Kassubek, P. Oeckl, H.-J. Huppertz, K. Fassbender, K. Fliessbach, J. Prudlo, J. Kornhuber, A. Schneider, A. Volk, M. Lauer, K. Fassbender, A. Danek, A. C. Ludolph, M. Otto: “Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias“ (Neurology (2017); 88 (10): 961-969)
  32. S. Bisenius, K. Mueller, J. Diehl-Schmid, K. Fassbender, T. Grimmer, F. Jessen, J. Kassubek, J. Kornhuber, B. Landwehrmeyer, A. Ludolph, A. Schneider, S. Anderl-Straub, K. Stuke, A. Danek, M. Otto, M. L. Schroeter, FTLDc study group: “Predicting primary progressive aphasias with support vector machine approaches in structural MRI data” (Neuroimage Clinical (2017); 14: 334-343)
  33. B. Lindner-Pfleghar, H. Neugebauer, S. Stösser, J. Kassubek, A. Ludolph, R. Dziewas, M. Prosiegel, A. Riecker: „Dysphagiemanagement beim akuten Schlaganfall: eine prospektive Studie zur Überprüfung der geltenden Empfehlungen“ (Nervenarzt (2017); 88 (2): 173-179)
  34. L. Timmermann, C. Oehlwein, G. Ransmayr, H. Fröhlich, E. Will, H. Schroeder, T. Lauterbach, L. Bauer, J. Kassubek: „Patients’ perception of Parkinson’s disease-associated pain following initiation of rotigotine: a multicenter non-interventional study” (Postgraduate Medicine (2017); 129 (1): 46-54)
  1. M. Gorges, H.-P- Müller, E. H. Pinkhardt, J. Kassubek, A. C. Ludolph: "In vivo-Staging der zentralen Neuropathologie bei Amyotropher Lateralsklerose: Konzepte mittels Diffusionstensor-Bildgebung und Video-Okulographie" (Klinische Neurophysiologie (2015); 46 (4): 182-185)                 
  2. C. Trenkwalder, K. R. Chaudhuri, P. Martinez-Martin, O. Rascol, R. Ehret, M. Vališ, M. Sátori, A. Krygowska-Wajs, M. J. Marti, K. Reimer, A. Oksche, M. Lomax, J. DeCesare, M. Hopp, PANDA study group [including J. Kassubek]: „Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial” (Lancet Neurology (2015); 14 (12): 1161-1170)   
  3. K. Fischer, D. Moewes, H.-P. Müller, G. Jacobs, J. Kassubek, W. Lieb, U. Nöthlings: "Association of Habitual Patterns and Types of Physical Activity and Inactivity with MRI-determined Total Volumes of Visceral and Subcutaneous Abdominal Adipose Tissue in a General White Population" (Public Library of Science (PLoS) One (2015); 10 (11): e0143925)
  4. A. Jahic, M. Khundadze, N. Jaenisch, R. Schüle, S. Klimpe, S. Klebe, C. Frahm, J. Kassubek, G. Stevanin, L. Schöls, A. Brice, C. A. Hübner, C. Beetz: "The spectrum of KIAA0196 variants, and characterization of a murine knockout: implications for the mutational mechanism in hereditary spastic paraplegia type SPG8" (Orphanet Journal of Rare Diseases (2015); 10 (1): 147 (1-10))
  5. H. Urbach, S. Rauer, I. Mader, S. Paus, J. Wagner, M. P. Malter, H. Prüss, J. Lewerenz, J. Kassubek, H. Hegen, M. Auer, F. Deisenhammer, F. Ufer, C. G. Bien, A. Baumgartner: "Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis" (Neuroradiology (2015); 57 (12): 1203-1209)  
  6. M. Gorges, H.-P. Müller, D. Lulé, K. Del Tredici, J. Brettschneider, J. Keller, K. Pfandl, A. C. Ludolph, J. Kassubek, E. H. Pinkhardt: "Eye movement deficits are consistent with a staging model of pTDP-43 pathology in amyotrophic lateral sclerosis" (Public Library of Science (PLoS) One (2015); 10 (11): e0142546)
  7. D. Moewes, K. Fischer, M. Koch, W. Lieb, H.-P. Müller, G. Jacobs, J. Kassubek, U. Nöthlings: "Association of food consumption with total volumes of visceral and subcutaneous abdominal adipose tissue in a Northern German population" (British Journal of Nutrition (2015); 114 (11): 1929-1940)
  8. E. Diehl-Wiesenecker, C. A. von Arnim, L. Dupuis, H.-P. Müller, A. C. Ludolph, J. Kassubek: "Adipose tissue distribution in patients with Alzheimer's disease: a whole body MRI case-control study" (Journal of Alzheimer's Disease (2015); 48 (3): 825-832)
  9. A. Abdelhak,  A. Junker,  J. Brettschneider,  J. Kassubek,  A. C. Ludolph,  M. Otto, H. Tumani: "Brain-specific cytoskeletal damage markers in cerebrospinal fluid: Is there a common pattern between amyotrophic lateral sclerosis and primary progressive multiple sclerosis?" (International Journal of Molecular Sciences (2015); 16 (8): 17565-17588)
  10. J. Keller, M. Gorges, H. T. Horn, H. E. Aho-Özhan, E. H. Pinkhardt, I. Uttner, J. Kassubek, A. C. Ludolph, D. Lulé: "Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study" (Journal of Neurology (2015); 262 (8): 1918-1926)
  11. M. Filippi, F. Agosta, J. Grosskreutz, M. Benatar, J. Kassubek, E. Verstraete, M. R. Turner, on behalf of the Neuroimaging Society in ALS (NiSALS): "Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis" (Lancet Neurology (2015); 14 (8): 786-788)
  12. C. Zimmermann, R. Kalepu, M. Ponfick, H. Reichel, B. Cakir, S. Zierz, H.-J. Gdynia, J. Kassubek, A. C. Ludolph, A. Rosenbohm: "Histological characterization and biochemical analysis of paraspinal muscles in neuromuscularly healthy subjects" (Muscle and Nerve (2015); 52 (1): 45-54)
  13. C. D. Wurster, H. Graf, H. Ackermann, K. Groth, J. Kassubek*, A. Riecker* (*shared senior authorship): "Neural correlates of rate-dependent finger-tapping in Parkinson`s disease" (Brain Structure and Function (2015); 220 (3): 1637-1648)
  14. F. Lauda, T. Fangerau, K. Javaheripour-Otto, E. Pinkhardt, J. Kassubek, H. Tumani: "Natalizumab-associated cerebellar PML: a case report on how to slow down IRIS" (Journal of Neurology (2015); 262 (4): 1055-1057)
  15. A. Rosenbohm, D. Buckert, MD, N. Gerischer, T. Walcher, J. Kassubek, W. Rottbauer, A. C. Ludolph, P. Bernhardt: "Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography" (Journal of Neurology (2015); 262 (4): 949-956)
  16. K. Fischer, D. Moewes, M. Koch, H.-P. Müller, G. Jacobs, J. Kassubek, W. Lieb, U. Nöthlings: "MRI-determined total volumes of visceral and subcutaneous abdominal and trunk adipose tissue are differentially and sex-dependently associated with patterns of estimated usual nutrient intake in a Northern German population" (American Journal of Clinical Nutrition (2015); 101 (4): 794-807)
  17. A. Hermann, U. Reuner, J. Schaefer, P. Fathinia, T. Leimert, J. Kassubek, M. Leimert, A. C. Ludolph, A. Storch: "The diagnostic value of midbrain hyperechogenicity in ALS is limited for discriminating key ALS differential diagnoses" (BMC Neurology (2015); 15 (1): 33 (1-5))
  18. J. Roßkopf, H.-P. Müller, J. Dreyhaupt, M. Gorges, A. C. Ludolph, J. Kassubek: "Ex post facto assessment of diffusion tensor imaging metrics from different MRI protocols: preparing for multicenter studies in ALS" (Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2015); 16 (1-2): 92-101)
  19. M. Gorges, H.-P. Müller, D. Lulé, LANDSCAPE Consortium, E. H. Pinkhardt, A. C. Ludolph, J. Kassubek: "To rise and to fall: Functional connectivity in cognitively normal and cognitively impaired patients with Parkinson's disease" (Neurobiology of Aging (2015); 36 (4): 1727-1735)
  20. D. Wiesner, J. Sinniger, A. Henriques, S. Dieterlé, H.-P. Müller, V. Rasche, B. Ferger, S. Dirrig-Grosch, R. Soylu-Kucharz, A. Petersén, P. Walther, B. Linkus, J. Kassubek, P. C. Wong, A. C Ludolph, L. Dupuis: "Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein mediated neurodegeneration" (Human Molecular Genetics (2015); 24 (8): 2228-2240)
  21. D. Woitalla, J. Kassubek, L. Timmermann, T. Lauterbach, R. Berkels, F. Grieger, T. Müller: "Reduction of gastrointestinal symptoms in Parkinson´s disease after a switch from oral therapy to rotigotine transdermal patch: A non-interventional prospective multicenter trial" (Parkinsonism and Related Disorders (2015); 21 (3): 199-204)
  1. J. Roßkopf, H.-P. Müller, H.-J. Huppertz, A. C. Ludolph, E. H. Pinkhardt, J. Kassubek: "Frontal corpus callosum alterations in Progressive Supranuclear Palsy but not in Parkinson´s Disease" (Neurodegenerative Diseases (2014); 14 (4): 184-193)
  2. V. Grozdanov, C. Bliederhaeuser, W. P. Ruf, V. Roth, K. Fundel-Clemens, L. Zondler, D. Brenner, A. Martin-Villalba, B. Hengerer, J. Kassubek, A. C. Ludolph, J. H. Weishaupt, K. M. Danzer: "Inflammatory dysregulation of blood monocytes in Parkinson's disease patients" (Acta Neuropathologica (2014); 128 (5): 651-663)
  3. C. Burtscher, A. Baxmann, J. Kassubek, M. Hornyak, W. Matuja, E. Schmutzhard, A. S. Winkler: "Prevalence of restless legs syndrome in an urban population of eastern Africa (Tanzania)" (Journal of the Neurological Sciences (2014); 346 (1-2): 121-127)
  4. J. Heimrath, M. Gorges, J. Kassubek, H.-P. Müller, N. Birbaumer, A. C. Ludolph, D. Lulé: "Additional resources and the default mode network: evidence of increased connectivity and decreased white matter integrity in amyotrophic lateral sclerosis" (Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2014); 15 (7-8): 537-545)
  5. H.-P. Müller*, J. Kassubek*, G. Grön, R. Sprengelmeyer, A. C. Ludolph, S. Klöppel, N. Z. Hobbs, R. A. C. Roos, A. Duerr, S. J. Tabrizi, M. Orth, S. D. Süßmuth, G. B. Landwehrmeyer (*shared first authorship): "Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease" (Biomedical Engineering OnLine (2014); 13 (1): 128 (1-15))        
  6. K. S. Lindenberg, P. Weydt, H.-P. Müller, A. Bornstedt, A. C. Ludolph, G. B. Landwehrmeyer, W. Rottbauer, J. Kassubek, V. Rasche: "Two-point magnitude MRI for rapid mapping of brown adipose tissue and its application to the R6/2 mouse model of Huntington Disease" (Public Library of Science (PLoS) One (2014); 9 (8): e105556)  
  7. K. Eggert, C. Öhlwein, J. Kassubek, M. Wolz, A. Kupsch, A. Ceballos-Baumann, R. Ehret, U. Polzer, F. Klostermann, J. Schwarz, G. Fuchs, W. Jost, A. Albert, A. Haag, A. Hermsen, K. Lohmüller, K. Kuhn, M. Wangemann, W. H. Oertel: "Influence of the non-ergot dopamine agonist piribedil on vigilance in patients with Parkinson´s Disease and excessive daytime sleepiness (PIVICOG-PD): an 11-week randomized comparison trial against pramipexole and ropinirole" (Clinical Neuropharmacology (2014): 37 (4): 116-122)               
  8. R. Sprengelmeyer, M. Orth, H.-P. Müller, R. C. Wolf, G. Grön, M. S. Depping, J. Kassubek, D. Justo, E. M. Rees, S. Haider, J. H. Cole, N. Z. Hobbs, R. A. C. Roos, A. Dürr, S. J. Tabrizi, S. D. Süssmuth, G. B. Landwehrmeyer: "The neuroanatomy of sub-threshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study" (Psychological Medicine (2014); 44 (9): 1867–1878)        
  9. M. Gorges, H.-P. Müller, A. C. Ludolph, V. Rasche, J. Kassubek: "Intrinsic functional connectivity networks in healthy elderly subjects: a multiparametric approach with structural connectivity analysis" (BioMed Research International (2014); 2014: 947252 (1-14))
  10. M. Gorges, E. H. Pinkhardt, J. Kassubek: "Alterations of eye movement control in neurodegenerative movement disorders" (Journal of Ophthalmology (2014); 2014: 658243 (1-11))   
  11. J. Kassubek: "Diagnostic procedures during the course of Parkinson´s Disease" (Basal Ganglia (2014); 4 (1): 15-18)                        
  12. J. Kassubek, H.-P. Müller, K. Del Tredici, J. Brettschneider, E. H. Pinkhardt, D. Lulé, S. Böhm, H. Braak, A. C. Ludolph: "DTI analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology" (Brain (2014); 137 (6): 1733-1740)
  13. E. H. Pinkhardt, H. Issa, M. Gorges, R. Jürgens, D. Lulé, J. Heimrath, H.-P. Müller, A. C. Ludolph, W. Becker, J. Kassubek: "Do eye movement impairments in patients with small vessel cerebrovascular disease depend on lesion load or on cognitive deficits? A video-oculographic and MRI study" (Journal of Neurology (2014); 261 (4): 791-803)                     
  14. J. Kassubek, K. R. Chaudhuri, T. Zesiewicz, E. Surmann, B. Boroojerdi, K. Moran, L. Ghys, C. Trenkwalder: "Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hoc analysis of the RECOVER study" (BMC Neurology (2014); 14 (1): 42 (1-8)) 
  15. E. Tolosa, I. Litvan, G. U. Höglinger, D. Burn, A. Lees, M. V. Andrés, B. Gómez-Carrillo, T. León, T. Del Ser; TAUROS Investigators [including J. Kassubek]: "A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy" (Movement Disorders (2014); 29 (4): 470-478)               
  16. G. U. Höglinger, H.-J. Huppertz, S. Wagenpfeil, M. V. Andrés, V. Belloch, T. León, T. Del Ser; TAUROS MRI Investigators [including J. Kassubek]: "Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial" (Movement Disorders (2014); 29 (4): 479-487)                                               
  17. A. Storch*, J. Kassubek*, H. Tumani, V. A. Vladimirtsev, A. Hermann, V. L. Osakovsky, V. A. Baranov, V. G. Krivoshapkin, A. C. Ludolph (*shared first authorship): "Communicating hydrocephalus following eosinophilic meningitis is pathogenic for chronic Viliuisk Encephalomyelitis in Northeastern Siberia" (Public Library of Science (PLoS) One (2014); 9 (2): e84670)           
  18. A. Rosenbohm, S. D. Süssmuth, J. Kassubek, H.-P. Müller, C. Pontes, A. Abicht, S. Bulst, A. C. Ludolph, E. Pinkhardt: "Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II" (Muscle and Nerve (2014); 49 (3): 446-450)
  19. M. Hornyak, H. Scholz, R. Kohnen, J. Bengel, J. Kassubek, C. Trenkwalder: "What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications" (Sleep Medicine Reviews (2014); 18 (2): 153-164)
  20. A. Rosenbohm, J. Kassubek, P. Weydt, N. Marroquin, A. E. Volk, C. Kubisch, H.-J. Huppertz, M. Weber, P. M. Andersen, J. H. Weishaupt, A. C. Ludolph, and the ALS Schwaben Register Group: "Can lesions to the Motor Cortex induce Amyotrophic Lateral Sclerosis?" (Journal of Neurology (2014); 261 (2): 283-290)
  21. M. Schneider, H.-P. Müller, F. Lauda, H. Tumani, A. C. Ludolph, J. Kassubek, E.-H. Pinkhardt: "Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study" (Journal of Neural Transmission (2014); 121 (1): 41-47)
  1. C. Trenkwalder, H. Beneš, L. Grote, D. García-Borreguero, B. Högl, M. Hopp, B. Bosse, A. Oksche, K. Reimer, J. Winkelmann, R. P. Allen, R. Kohnen; RELOXYN Study Group [including J. Kassubek]: "Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension" (Lancet Neurology (2013); 12 (12): 1141-1150)
  2. H.-P. Müller, J. Kassubek: "Diffusion tensor magnetic resonance imaging in the analysis of neurodegenerative diseases" (Journal of Visualized Experiments (2013); 77: e50427)
  3. J. Kassubek, A. Danek, K. Del Tredici-Braak, M. W. Greenlee, E. H. Pinkhardt: "Das Auge als Zugang zur Pathophysiologie von Parkinsonsyndromen" (Nervenarzt (2013); 84 (8): 909-917)
  4. H.-P. Müller, H. G. Niessen, T. Kaulisch, A. C. Ludolph, J. Kassubek*, D. Stiller* (*shared senior authorship): "MRI allows for longitudinal quantitative analysis of body fat composition in rats: an analysis of sibutramine-associated changes at the group level" (Magnetic Resonance Imaging (2013); 31 (7): 1150-1155)
  5. H. Graf, M. Gorges, J. Kassubek: "Hypertrophe Degeneration des Nucleus olivaris: klinisches Bild" (Nervenheilkunde (2013); 32 (8): 532-537)
  6. H.-P. Müller*, J. Kassubek*, I. Vernikouskaya, A. C. Ludolph, D. Stiller, V. Rasche (*shared first authorship): "Diffusion tensor magnetic resonance imaging of the brain in APP transgenic mice: a cohort study" (Public Library of Science (PLoS) One (2013); 8 (6): e67630)
  7. E. Lindauer, L. Dupuis, H.-P. Müller, H. Neumann, A. C. Ludolph, J. Kassubek: "Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis" (Public Library of Science (PLoS) One (2013); 8 (6): e67783)
  8. M. Gorges, H.-P. Müller, D. Lulé, A. C. Ludolph, E. H. Pinkhardt, J. Kassubek: "Functional connectivity within the default mode network is associated with saccadic accuracy in Parkinson's disease: a resting state fMRI and videooculographic study" (Brain Connectivity (2013); 3 (3): 265-272)
  9. J. Kassubek: "Restless Legs Syndrom - klinische Diagnose" (MMW - Fortschritte der Medizin (2013); 155 (8): 68-70)
  10. H. S. Karcher, R. Holzwarth, H.-P. Müller, A. C. Ludolph, R. Huber, J. Kassubek, E. H. Pinkhardt: "Body fat distribution as a risk factor for cerebrovascular disease: A MRI based body-fat quantification study" (Cerebrovascular Diseases (2013); 35 (4): 341-348)
  11. H.-P. Müller, G. Grön, R. Sprengelmeyer, J. Kassubek, A. C. Ludolph, N. Z. Hobbs, J. Cole; R. A. Roos, A. Duerr, S. J. Tabrizi, B. Landwehrmeyer, S. Süssmuth: "Evaluating multicenter DTI data in Huntington's disease on site specific effects: an ex post facto approach" (NeuroImage: Clinical (2013); 2 (1): 161-167)
  12. P. Fathinia, A. Hermann, U. Reuner, J. Kassubek (corresponding author), A. Storch, A. C. Ludolph: "Parkinson’s disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis" (Journal of Neurology (2013); 260 (2): 454-457)
  1. S. Jesse, J. Kassubek (corresponding author), H.-P. Müller, A. C. Ludolph, A. Unrath:"Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis"(BMC Neurology (2012); 12 (1): 163 (1-8))
  2. H.-P. Müller, I. Vernikouskaya, A. C. Ludolph, J. Kassubek, V. Rasche: "Fast diffusion tensor magnetic resonance imaging of the mouse brain at ultrahigh-field: aiming at cohort studies" (Public Library of Science (PLoS) One (2012); 7 (12): e53389)
  3. T. Klein, H. G  Niessen, C. Ittrich, E. Mayoux, H. P. Müller, S. Cheetham, D. Stiller, J. Kassubek, M. Mark: "Evaluation of body fat composition after linagliptin treatment in a rat model of diet-induced obesity: a magnetic resonance spectroscopy study in comparison with sibutramine" (Diabetes, Obesity and Metabolism (2012); 14 (11): 1050-1053)
  4. A. Unrath, A. C. Ludolph, J. Kassubek: "Reversible cortical diffusion restriction, hyperperfusion and T2-hyperintensities caused by two different types of epileptic seizures" (Clinical Neuroradiology (2012); 22 (3): 239-243)
  5. U. Wüllner, G. Fuchs, N. Reketat, O. Randerath, J. Kassubek: "Requirements for Parkinson's disease pharmacotherapy from the patients' perspective: a questionnaire-based survey" (Current Medical Research and Opinion (2012); 28 (7): 1239-1246)
  6. C. Dufke, N. Schlipf, R. Schüle, M. Bonin, M. Auer-Grumbach, G. Stevanin, C. Depienne, J. Kassubek, S. Klebe, S. Klimpe, T. Klopstock, S. Otto, S. Poths, A. Seibel, H. Stolze, A. Gal, L. Schöls, P. Bauer: "A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes" (Neurogenetics (2012); 13 (3): 215-227)
  7. L. Dupuis, R. Dengler,  M. T. Heneka, T. Meyer, S. Zierz, J. Kassubek, W. Fischer, F. Steiner, E. Lindauer, M. Otto, J. Dreyhaupt, T. Grehl, A. Hermann, A. S. Winkler, U. Bogdahn, R. Benecke, B. Schrank, C. Wessig, J. Grosskreutz, A. C. Ludolph, GERP ALS Study Group: "A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis" (Public Library of Science (PLoS) One (2012); 7 (6): e37885)
  8. M. Hornyak, H. Scholz, A. Kiemen, J. Kassubek: "Investigating the response to intravenous iron in restless legs syndrome: an observational study"(Sleep Medicine (2012); 13 (6): 732-735)
  9. M. Ponfick, A. C. Ludolph, G. Dekomien, I. Uttner, J. Kassubek,  H-J. Gdynia:"Inclusion Body Myositis mit Morbus Paget und frontotemporaler Demenz: frühe Beteiligung des Herzens und der Atemmuskulatur (Fortschritte der Neurologie Psychiatrie(2012);80(6):344-347)
  10. H.-P. Müller, A. Unrath, H.-J. Huppertz, A. C. Ludolph, J. Kassubek: "Neuroanatomical patterns of cerebral white matter involvement in different motor neuron diseases as studied by diffusion tensor imaging analysis" (Amyotrophic Lateral Sclerosis (2012); 13 (3): 254-264)
  11. E. H. Pinkhardt, R. Jürgens, D. Lulé, J. Heimrath, A. C Ludolph, W. Becker, J. Kassubek: "Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms" (BMC Neurology (2012): 12: 5 (1-8))
  12. J. Kassubek, C. Langkammer: "Neuroimaging – Möglichkeiten und Grenzen: Amyotrophe Lateralsklerose" (Neurologisch (2012); 1: 51-53)
  13. J. Kassubek, A. C. Ludolph, H.-P. Müller: "Neuroimaging of motor neuron diseases" (Therapeutic Advances in Neurological Disorders (2012): 5 (2): 119-127)
  14. J. Kassubek, A.-D. Sperfeld, E. H. Pinkhardt, A. Unrath, H.-P. Müller, K. Scharffetter-Kochanek, A. C. Ludolph, M. Berneburg: "The cerebro-morphological fingerprint of a progeroid syndrome: white matter changes correlate with neurological symptoms in xeroderma pigmentosum" (Public Library of Science (PLoS) One; 7 (2): e30926)
  15. J. Kassubek, A. C. Ludolph: "Neurotoxikologie des Alkohols: Gefahr durch Komplikationen und Folgeerkrankungen" (NeuroTransmitter (2012); 22 (1): 30-35)
  16. S. Klimpe, R. Schüle, J. Kassubek, S. Otto, Z. Kohl, S. Klebe, T. Klopstock, S. Ratzka, K. Karle, L. Schöls: "Disease severity affects quality of life of hereditary spastic paraplegia patients" (European Journal of Neurology (2012); 19 (1): 168-171)
  17. D. Lulé, J. Heimrath, E. H. Pinkhardt, A. C. Ludolph, I. Uttner, J. Kassubek: "Deep brain stimulation and behavioural changes: is the co-medication the most important factor?" (Neurodegenerative Diseases (2012); 9 (1): 18-24)
  1. H.-P. Müller, S. D. Süßmuth, G. B. Landwehrmeyer, A. C. Ludolph, S. J. Tabrizi, S. Klöppel, J. Kassubek: "Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington’s disease" (Public Library of Science (PLoS) Currents (2011); 3: RRN1292)
  2. J. Kassubek, B. Abler, E. H. Pinkhardt: "Neural reward processing under dopamine agonists: Imaging" (Journal of the Neurological Sciences (2011); 310 (1-2): 36-39)
  3. A. Unrath, H.-P. Müller, J. Kassubek: „Voxel-basierte MR-Morphometrie und Diffusionstensorbildgebung: Grundlagen und Anwendungen in der klinischen Neurologie“ (Journal für Neurologie, Neurochirurgie und Psychiatrie (2011); 12 (3): 272-279)
  4. M. Gedack, M. M. Hänle, C. Schönfeldt-Lecuona, W. Kratzer, J. Kassubek, D. Brummer, B. J. Connemann; EMIL Study Group: "Serumcoeruloplasmin in einer randomisierten Bevölkerungsstichprobe mit 2 445 Probanden" (Nervenheilkunde (2011); 30 (8): 555-561)
  5. J. Kassubek, E. H. Pinkhardt, A. Dietmaier, A. C. Ludolph, G. B. Landwehrmeyer, H.-J. Huppertz: „Fully-automated atlas-based MRI volumetry in Huntington´s disease, compared with manual volumetry“ (American Journal of Neuroradiology (2011); 32 (7): 1328-1332)
  6. A. C. Ludolph, J. Kassubek: "Erweiterte therapeutische Strategien bei neurologischen Erkrankungen: Gegenwart und Perspektiven" (Nervenarzt (2011); 82 (8): 955-956)   
  7. H.-P. Müller, V. Glauche, M. J. U. Novak, T. T. Nuguyen, A. Unrath, N. Lahiri, J. Read, M. Say, S. Tabrizi, J. Kassubek (corresponding author), S. Klöppel: "Stability of white matter changes related to Huntington’s disease in the presence of imaging noise: a DTI study" (Public Library of Science (PLoS) Currents (2011); 3: RRN1232)
  8. G. Röderer, A.-D. Sperfeld, P. Hansen, G. Krischak, F. Gebhard, J. Kassubek: "Electrophysiological assessment of the deltoid muscle after minimally invasive treatment of proximal humerus fractures - a clinical observation" (The Open Orthopaedics Journal (2011); 5: 223-228)
  9. J. Winkler, R. Ehret, T. Büttner, U. Dillmann, W. Fogel, M. Sabolek, J. Winkelmann, J. Kassubek: “Parkinson’s disease risk score: Moving to a premotor diagnosis” (Journal of Neurology (2011); 258 (Suppl 2): S311-315)
  10. M. Ponfick, H.-J. Gdynia, A. C. Ludolph, J. Kassubek: "Camptocormia in Parkinson´s disease - a review of the literature" (Neurodegenerative Diseases (2011); 8 (5): 283-288)
  11. A. Unrath, A. C. Ludolph, J. Kassubek: “Alterations of the corpus callosum as an MRI-based hallmark of motor neuron diseases” (American Journal of Neuroradiology (2011); 32 (5): E90)
  12. E. H. Pinkhardt, J. Kassubek: "Die Untersuchung der Okulomotorik als differenzialdiagnostisches Instrument bei Parkinson-Syndromen“ (Nervenheilkunde (2011); 30 (4): 259-262)
  13. M. Ponfick, H.-J. Gdynia, J. Kassubek, A. C. Ludolph, K. Petscher, T. Walcher, D. Walcher, P. Bernhardt: „Cardiac involvement in juvenile overlap-myositis detected by cardiac magnetic resonance imaging“ (International Journal of Cardiology (2011); 152(1): e25-26)
  14. E. H. Pinkhardt, J. Kassubek: “Ocular motor abnormalities in Parkinsonian syndromes” (Parkinsonism and Related Disorders (2011); 17 (4): 223-230)
  15. M. R. Turner, J. Grosskreutz, J. Kassubek, S. Abrahams, F. Agosta, M. Benatar, M. Filippi, L. H. Goldstein, M. van den Heuvel, S. Kalra, D. Lulé, B. Mohammadi; ‘The 1st NISALS’ Group: “Towards a neuroimaging biomarker in amyotrophic lateral sclerosis” (Lancet Neurology (2011); 10 (5): 400-403)
  16. H. Tumani*, J. Kassubek*, M. Hijazi, V. Lehmensiek, A. Unrath, S. Süssmuth, F. Lauda, T. Kapfer, L. Fang, M. Senel, J. Brettschneider (* shared first authorship): “Patterns of Th1/Th2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetate” (European Neurology (2011); 65 (3): 164-169)
  17. J. Dorst, P. Kühnlein, C. Hendrich, J. Kassubek, A.-D. Sperfeld, A. C. Ludolph: „Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in Amyotrophic Lateral Sclerosis“ (Journal of Neurology (2011); 258 (4): 613-617)
  18. C. Trenkwalder, B. Kies, M. Rudzińska, J. Fine, J. Nikl, K. Honczarenko, P. Dioszeghy, D, Hill, T. Anderson, V. Myllylä, J. Kassubek, M. Steiger, M. Zucconi, E. Tolosa, W. Poewe, E. Surmann, J. Whitesides, B. Boroojerdi, K. R. Chaudhuri: "Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: A double-blind, randomised, placebo-controlled study (RECOVER)" (Movement Disorders (2011): 26 (1): 90-99)
  19. J. Kassubek, B. Abler: "Das Dopamin-Dysregulations-Syndrom" (Neuro Aktuell (2011); 1: 9-13)
  20. H.-P. Müller, F. Raudies, A. Unrath, H. Neumann, A. C. Ludolph, J. Kassubek: „Quantification of human body fat tissue percentage by magnetic resonance imaging” (NMR in Biomedicine (2011); 24 (1): 17-24)
  21. H.-P. Müller, D. Lulé, A. Unrath, A. C. Ludolph, A. Riecker, J. Kassubek: “Complementary image analysis of diffusion tensor imaging and 3-D T1-weighted imaging: white matter analysis in amyotrophic lateral sclerosis” (Journal of Neuroimaging (2011); 21 (1): 24-33)
  1. A. Unrath, H.-P. Müller, A. Riecker, A. C. Ludolph, A.-D. Sperfeld, J. Kassubek: "Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging” (Human Brain Mapping (2010); 31 (11): 1727-1740)
  2. K. E. Braunstein, J. Eschbach, K. Ròna-Vörös, R. Soylu, E. Mikroul, Y. Larmet, F. Rene, J.-L. Gonzalez de Aguilar, J.-P. Loeffler, H.-P. Müller, S. Bucher, T. Kaulisch, H. G. Niessen, J. Tillmanns, K. Fischer, B. Schwalenstöcker, J. Kassubek, B. Pichler, D. Stiller, Å. Petersen, A. C. Ludolph, L. Dupuis: “A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons” (Human Molecular Genetics (2010); 19 (22): 4385-4398)
  3. B. J. Connemann, C. Schönfeldt-Lecuona, H.-J. Maxon, W. Kratzer, J. Kassubek: “Die Bedeutung des Serum-Coeruloplasmins für die Differenzialdiagnose neuropsychiatrischer Störungen” (Fortschritte der Neurologie Psychiatrie (2010); 78 (10): 582-589)
  4. M. Kölle, P. Lepping, J. Kassubek, C. Schönfeldt-Lecuona, R. W. Freudenmann: “Delusional infestation induced by piribedil add-on in Parkinson’s Disease” (Pharmacopsychiatry (2010); 43 (6): 240-242)
  5. J. Brettschneider, A. Czerwoniak, M. Senel, L. Fang, J. Kassubek, E. H. Pinkhardt, F. Lauda, T. Kapfer, V. Lehmensiek, A. C. Ludolph, M. Otto, H. Tumani: “The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS)” (Public Library of Science (PLoS) One; 5 (8): e11986)
  6. D. Lulé, V. Diekmann, H.-P. Müller, J. Kassubek, A. C. Ludolph, N. Birbaumer: “Neuroimaging of multimodal sensory stimulation in Amyotrophic Lateral Sclerosis (ALS)” (Journal of Neurology, Neurosurgery, and Psychiatry (2010); 81 (8): 899-906)
  7. S. D. Süssmuth, I. Uttner, B. Landwehrmeyer, E. H. Pinkhardt, J. Brettschneider, A. Petzold, B. Kramer, J. B. Schulz, C. Palm, M. Otto, A. C. Ludolph, J. Kassubek, H. Tumani: “Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes” (Movement Disorders (2010); 5 (9): 1284-1288)
  8. E. H. Pinkhardt, A.-D. Sperfeld, I. Uttner, A. C. Ludolph, J. Kassubek: “Amygdala size reduction is associated with memory deficits in complicated hereditary spastic paraparesis: an MRI study” (European Neurology (2010); 64 (2): 117-123)
  9. U. Wüllner, J. Kassubek, P. Odin, M. Schwarz, M. Naumann, H.-J. Häck, B. Boroojerdi, H. Reichmann: ”Transdermal rotigotine for the perioperative management of Parkinson’s disease” (Journal of Neural Transmission (2010); 117 (7): 855-859)
  10. A. Riecker, K. Gröschel, S. Schnaudigel, J. Kassubek, A. Kastrup: "The role of the unaffected hemisphere in motor recovery after stroke" (Human Brain Mapping (2010); 31 (7): 1017-1029)
  11. P. Fischer-Posovszky, J. von Schnurbein, B. Moepps, G. Lahr, G. Strauss, T. F. Barth, J. Kassubek, H. Mühleder, P. Möller, K.-M. Debatin, P. Gierschik, M. Wabitsch: “A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness” (Journal of Clinical Endocrinology and Metabolism (2010); 95 (6): 2836-2840)
  12. A. S. Winkler, E. Tütüncü, A. Trendafilova, M. Meindl, J. Kaaya, E. Schmutzhard, J. Kassubek: “Parkinsonism in a population of northern Tanzania: a community-based door-to-door study in combination with a prospective hospital-based evaluation” (Journal of Neurology (2010); 257 (5): 799-805)
  13. A. S. Winkler, A. Trendafilova, M. Meindl, J. Kaaya, E. Schmutzhard, J. Kassubek:"Restless legs syndrome in a population of northern Tanzania: a community-based study"(Movement Disorders (2010); 25 (5): 596-601)
  14. S. M. Henley, G. Ridgway, R. I. Scahill, S. Klöppel, S. J Tabrizi, N. C. Fox, J. Kassubek: "Pitfalls in the use of voxel-based morphometry as a biomarker: examples from Huntington´s disease"(American Journal of Neuroradiology (2010); 31 (4): 711-719)
  15. M. Filippi, F. Agosta, S. Abrahams, F. Fazekas, J. Grosskreutz, S. Kalra, J. Kassubek, V. Silani, M.R. Turner, J. C. Masdeu:"EFNS Guideline on the use of neuroimaging in the management of motor neuron diseases."(European Journal of Neurology (2010); 17 (4): 526-533)
  16. Y.G. Weber, R. Roebling, J. Kassubek, S. Hoffmann, A. Rosenbohm, M. Wolf, P. Steinbach, K. Jurkat-Rott, H. Walter, S.N. Reske, F. Lehmann-Horn, F.M. Mottaghy, H. Lerche: "Comparative analysis of brain structure, metabolism and cognition in myotonic dystrophy 1 and 2"(Neurology (2010); 74 (14): 1108-1117)
  17. J. Kassubek, T. Büttner, H. Reichmann, P. Riederer, J. B. Schulz, U. Wüllner, I. Csoti: "Stellenwert von MAO-B-Inhibitoren und NMDA-Antagonisten in der Therapie des Morbus Parkinson"(Fortschritte der Neurologie Psychiatrie (2010); 78 (Suppl. 1): S34-S36)
  18. H. Walter, S. Heckers, J. Kassubek, S. Erk, K. Frasch, B. Abler:"Further evidence for aberrant prefrontal salience coding in schizophrenia"(Frontiers in Behavioral Neuroscience (2010); 3: 62 (1-9))
  19. H.-J. Huppertz, J. Kröll-Seger, S. Klöppel, R. E. Ganz, J. Kassubek:"Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures"(NeuroImage (2010); 49 (3): 2216-2224)
  1. E. H. Pinkhardt, J. Kassubek(corresponding author), S. Süssmuth, A. C. Ludolph, W. Becker, R. Jürgens: "Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's Disease" (Journal of Neurology (2009); 256 (9): 1438-1446)
  2. B. Abler, R. Hahlbrock, A. Unrath, G. Grön, J. Kassubek: "At risk for pathological gambling: Imaging neural reward processing under chronic dopamine agonists" (Brain (2009); 132 (9): 2396-2402)
  3. M. Hornyak, H. Benes, I. Eisensehr, J. Haan, J. Kassubek, I. Peglau, K. Stiasny-Kolster, C. Trenkwalder: "Depressive Erkrankungen bei Restless Legs Syndrom: Pathogenese, Diagnose und Implikationen für die Therapie" (Nervenarzt (2009); 80 (10): 1160-1168)
  4. S. Klöppel, S. Henley, N. Hobbs, R. C. Wolf, J. Kassubek, S. J. Tabrizi, R. Frackowiak: "Magnetic resonance imaging of Huntington's Disease: Preparing for clinical trials" (Neuroscience (2009); 164 (1): 205-219)
  5. G. R. Soukup, A.-D. Sperfeld, I. Uttner, J. Karitzky, A. C. Ludolph, J. Kassubek*, H. Schreiber* (* shared senior authorship): "Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled neuropsychological study of 20 patients" (Journal of Neurology (2009); 56 (11): 1869-1875)
  6. H.-J. Gdynia, A.-D. Sperfeld, A. Unrath, A. C. Ludolph, M. Sabolek, A. Storch, J. Kassubek: "Histopathological analysis of skeletal muscle in patients with Parkinson´s disease and 'Dropped head' / 'Bent spine' syndrome" (Parkinsonism and Related Disorders (2009); 15 (9): 633-639)
  7. D. Lulé, A.C. Ludolph, J. Kassubek: "MRI-based functional neuroimaging in ALS: an update" (Amyotrophic Lateral Sclerosis (2009); 10 (5-6): 258-268)   
  8. D. Ecker, A. Unrath, J. Kassubek, M. Sabolek: “Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study” (BMC Neurology (2009); 9 (1): 23)
  9. E. H. Pinkhardt, A.-D. Sperfeld, H.-J. Gdynia, A. C. Ludolph, J. Kassubek: "The combination of dopa responsive Parkinsonian syndrome and motor neuron disease" (Neurodegenerative Diseases (2009); 6 (3): 95-101)       
  10. R. Roebling, K. Huch, J. Kassubek, H. Lerche, Y. Weber: „Cervical spinal MRI in a patient with vagus nerve stimulator” (Epilepsy Research (2009); 84 (2-3): 273-275)
  11. J. Kassubek, A. Unrath: „Unruhige Beine, unruhige Nächte: leidet Ihr Patient an einem Restless Legs Syndrom?“ (MMW - Fortschritte der Medizin (2009); 151 (13): 65-69)
  12. H.-P. Müller, A. Unrath, A. Riecker, E. H. Pinkhardt, A. C. Ludolph, J. Kassubek: "Inter-subject variability in the analysis of diffusion tensor images at the group level: fractional anisotropy mapping and fiber tracking techniques" (Magnetic Resonance Imaging (2009); 27 (3): 324-334)
  13. E. H. Pinkhardt, J. Kassubek, D. Brummer, M. Kölch, A. C. Ludolph, J. M. Fegert, A. G. Ludolph: "Intensified testing for attention-deficit hyperactivity disorder (ADHD) in girls should reduce depression and smoking in adult females and the prevalence of ADHD in the longterm" (Medical Hypotheses (2009); 72 (4): 409-412)
  14. A. C. Ludolph *, J. Kassubek *, G. B. Landwehrmeyer *, E. Mandelkow, E.-M. Mandelkow, D. J. Burn, D. Caparros-Lefebvre, K. A. Frey, J. Garcia de Yebenes, T. Gasser, P. Heutink, G. Höglinger, Z. Jamrozik, K. A. Jellinger, A. Kazantsev, H. Kretzschmar, A. E. Lang, I. Litvan, J. J. Lucas, P. L. McGeer, S. Melquist, W. Oertel, M. Otto, D. Paviour, T. Reum, A. Saint-Raymond, J. C. Steele, M. Tolnay, H. Tumani, J. C. van Swieten, M. T. Vanier, J.-P. Vonsattel, S. Wagner, Z. K. Wszolek, for the Reisensburg Working Group for Tauopathies With Parkinsonism (* shared 1st authorship): "Tauopathies with Parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options" (European Journal of Neurology (2009): 16 (3): 297-309)
  15. A. Riecker, R. Gastl, P. Kuehnlein, J. Kassubek, M. Prosiegel: "Dysphagia due to unilateral infarction in the vascular territory of the anterior insula" (Dysphagia (2009); 24 (1): 114-118)
  16. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; for the NNIPPS Study Group [including J. Kassubek]: “Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study” (Brain 2009; 132 (1): 156-171)
  17. H.-J. Huppertz, M. Kurthen, J. Kassubek: "Voxel-based 3D MRI analysis for the detection of epileptogenic lesions at single subject level"  Epilepsia (2009); 50 (1): 155-156)
  18. W. Becker, R. Jürgens, J. Kassubek, D. Ecker, B. Kramer, B. Landwehrmeyer: "Eye-head coordination in moderately affected Huntington's Disease patients: Do head movements facilitate gaze shifts?" (Experimental Brain Research (2009); 192 (1): 97-112)
  1. E. H. Pinkhardt, R. Jürgens, W. Becker, F. Valdarno, A. C. Ludolph, J. Kassubek: "Differential diagnostic value of eye movement recording in PSP-Parkinsonism, Richardson’s syndrome, and idiopathic Parkinson’s disease" (Journal of Neurology (2008); 255 (12): 1916-1925)
  2. H.-J. Huppertz, J. Kröll-Seger, A. Danek, B. Weber, T. Dorn,J. Kassubek: "Automatic striatal volumetry allows for identification of patients with chorea-acanthocytosis at single subject level" (Journal of Neural Transmission (2008); 115 (10): 1393-1400)
  3. M. Orth, J. Kassubek: "Huntingtonsche Krankheit" (PsychoNeuro (2008); 34 (8): 367-371)
  4. C. Steinbrink, K. Vogt, A. Kastrup, H.-P. Müller, F. D. Juengling, J. Kassubek*, A. Riecker* (* shared senior authorship): "The contribution of white and gray matter differences to developmental dyslexia: insights from DTI and VBM at 3.0 Tesla" (Neuropsychologia (2008); 46 (13): 3170-3178)
  5. J. Brettschneider, A.-D. Sperfeld, A. C. Ludolph, J. Kassubek: "Intracerebral haemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship?" (Muscle and Nerve (2008); 38 (3):1211-1212)
  6. C. Trenkwalder, H. Beneš, W. Poewe, W. H. Oertel, D. Garcia-Borreguero, A. W. de Weerd, L. Ferini-Strambi, P. Montagna, P. Odin, K. Stiasny-Kolster, B. Högl, K. R. Chaudhuri, M. Partinen, E. Schollmayer, R. Kohnen; for the SP790 Study Group [B. Högl, W. Poewe, D. Volc, M. Partinen, O. Pol, D. Backhaus, S. Behrens, H. Beneš, B. Bergtholdt, R. Bodenschatz, M. Canelo, I. Eisensehr, W. Fogel, P. Franz, P. Geisler, B. Gestewitz, J. Haan, S. Happe, H. Henin, G. Karlbauer, J. Kassubek, M. Lang, W. Lünser, I. Maier, P. Odin, W. H. Oertel, W. Paulus, I. Peglau, K. Schlinsog, I. Schöll, A. Schulze, G. Schumann, A. Siever, K.-O. Sigel, H. Sommer, K. Stiasny-Kolster, K. Tinschert, C. Trenkwalder, L. Ferini-Strambi, F. Ferrillo, G. L. Gigli, R. Manni, P. Montagna, A. W. de Weerd, E. Estivill, D, García-Borreguero, F, J, Puertas, Y. Hallström, R. Palm, K. R. Chaudhuri, J. Robinson, S. Taylor, M. Thompson]: "Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial" (Lancet Neurology (2008); 7 (7): 595-604)
  7. A. Unrath, H.-P. Müller, A. C. Ludolph, A. Riecker, J. Kassubek: "Cerebral white matter alterations in idiopathic restless legs syndrome, as measured by diffusion tensor imaging" (Movement Disorders (2008); 23 (9): 1250-1255)
  8. W. Freund, J. Kassubek, A. Aschoff, R. Huber: "MRI-based separation of congenital and acquired vertebrobasilar artery anomalies in ischemic stroke of the posterior circulation" (Stroke (2008); 39 (8): 2382-2384)
  9. J. Grosskreutz, T. Peschel, A. Unrath, R. Dengler, A.C. Ludolph, J. Kassubek: "Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders" (Amyotrophic Lateral Sclerosis (2008); 9 (4): 238-248)
  10. A. G. Ludolph, E. H. Pinkhardt, L. T. van Elst, G. Libal, A. C. Ludolph, J. M. Fegert, J. Kassubek: "Amygdalar volume alterations in children with Tourette syndrome: due to ADHD comorbidity?" (Developmental Medicine and Child Neurology (2008); 50 (7): 524-529)
  11. A. G. Ludolph, J. Kassubek, K. Schmeck, C. Glaser, A. Wunderlich, A. K. Buck, S. N. Reske, J. M. Fegert, F. M. Mottaghy: "Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-L-alanine PET study" (NeuroImage (2008); 41 (3): 718-727)
  12. E. H. Pinkhardt, A.-D. Sperfeld, V. Bretschneider, A. Unrath, A. C. Ludolph, J. Kassubek: "Is spinal epidural lipomatosis an MRI-based diagnosis with clinical implications? A retrospective analysis" (Acta Neurologica Scandinavica (2008); 117 (6): 409-414)
  13. R. Schüle, B. P. H. Kremer, J. Kassubek, M. Auer-Grumbach, V. S. Kostic, T. Klopstock, S. Klimpe, S. Otto, S. Bösch, B. P. C. van de Warrenburg, L. Schöls: "SPG10 is a rare cause of spastic paraplegia in European families" (Journal of Neurology, Neurosurgery and Psychiatry (2008); 79 (5): 584-587)
  14. A. Unrath, U. Klose, W. Grodd, A. C. Ludolph, J. Kassubek: "Directional colour encoding of the human thalamus by diffusion tensor imaging" (Neuroscience Letters (2008); 434 (3): 322-327)
  15. H. J. Gdynia, T. Müller, A.-D. Sperfeld, P. Kuehnlein, M. Otto, J. Kassubek, A. C. Ludolph: "Severe sensorimotor neuropathy after Intake of highest dosages of vitamin B6" (Neuromuscular Disorders (2008); 18 (2): 156-158)
  16. C. Beetz, R. Schüle, T. Deconinck, K.-N. Tran-Viet, H. Zhu, B. P. H. Kremer, S. G.M. Frints, W. A.G. van Zelst-Stams, P. Byrne, S. Otto, A. O. Nygren, J. Baets, K. Smets, B. Ceulemans, B. Dan, N. Nagan, J. Kassubek, S. Klimpe, T. Klopstock, H. Stolze, H. J. Smeets, C. T. Schrander-Stumpel, M. Hutchinson, B. P. van de Warrenburg, C. Braastad, T. Deufel, M. Pericak-Vance, L. Schöls, P. de Jonghe, S. Züchner: "REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31" (Brain (2008); 131 (4): 1078-1086)
  17. H.-J. Huppertz, J. Kassubek, D.-M. Altenmüller, T. Breyer, S. Fauser: "Automatic curvilinear reformatting of three-dimensional MRI data of the cerebral cortex" (NeuroImage (2008); 39 (1): 80-86)
  1. J. Kassubek, A.-D. Sperfeld: "Differenzialdiagnostik der spastischen Spinalparalyse" (PsychoNeuro (2007); 33 (11): 467-470)
  2. J. Kassubek: "Einsatz von Rotigotin bei fortgeschrittener Parkinson-Erkrankung" (Aktuelle Neurologie (2007); 34 (Suppl. 4): S279-S283)
  3. J. Kassubek, F. D. Juengling, A. Baumgartner, A. Unrath, A. C. Ludolph, A.-D. Sperfeld: "Different regional brain volume loss in pure and complicated hereditary spastic paraparesis: a voxel-based morphometric study" (Amyotrophic Lateral Sclerosis (2007); 8 (6): 328-336)
  4. J. Kassubek, F. D. Juengling, A.-D. Sperfeld: "Widespread white matter changes in Kennedy Disease: a voxel-based morphometry study" (Journal of Neurology, Neurosurgery and Psychiatry (2007); 78 (11): 1209-1212)
  5. D. Lulé, V. Diekmann, J. Kassubek, A. Kurt, N. Birbaumer, A. C. Ludolph, E. Kraft: "Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function" (Neurorehabilitation and Neural Repair (2007); 21 (6): 518-526)
  6. A. Unrath, J. Kassubek: "Computer-based 3-D MRI analysis in amyotrophic lateral sclerosis: common and specific factors among studies" (American Journal of Neuroradiology (2007); 28 (9): 1626)
  7. A. Unrath, F. D. Juengling, M. Schork, J. Kassubek: "Corticaal grey matter alterations in idiopathic restless legs syndrome: an optimized voxel-based morphometry study" (Movement Disorders (2007); 22 (12): 1751-1756)
  8. R. Viviani, P. Beschoner, T. Jaeckle, P. Hipp, J. Kassubek, B. Schmitz: "The bootstrap and cross-validation in neuroimaging applications: Estimation of the distribution of extrema of random fields for single volume tests, with an application to ADC maps" (Human Brain Mapping (2007); 28 (10): 1075-1088)
  9. A. Unrath, A. C. Ludolph, J. Kassubek: "Brain metabolites in definite amyotrophic lateral sclerosis: a longitudinal proton magnetic resonance spectroscopy study" (Journal of Neurology (2007); 254 (8): 1099-1106)
  10. J. Kassubek: "Improved screening for a widespread disorder with therapeutic options: restless legs syndrome" (European Journal of Neurology (2007); 14 (9): 951)
  11. C. Ikonomidou, I. Scheer, T. Wilhelm, F. Juengling, K. Titze, B. Stoever, U. Lehmkuhl, S. Koch, J. Kassubek: "Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs" (European Journal of Paediatric Neurology (2007); 11 (5): 297-301)
  12. H. Ammermann*, J. Kassubek*, M. Lotze, E. Gut, M. Kaps, J. Schmidt, F. A. Rodden, W. Grodd (* shared 1st authorship): "MRI brain lesion patterns in patients in anoxia induced vegetative state" (Journal of the Neurological Sciences (2007); 260 (1-2): 65-70)
  13. J. Kassubek, S. Braune, T. Büttner, G. Fuchs, W. Greulich, M. Hahne, M. Müngersdorf, I. Reuter: "Dopaminerge Stimulation: orale Applikation mit kontrollierter Freisetzung versus transdermale Applikation" (Aktuelle Neurologie (2007); 34 (Suppl. 1): S31-S32)
  14. H.-J. Gdynia, A.-D. Sperfeld, L. Flaith, P. Kuehnlein, A. Unrath, A. C. Ludolph, J. Kassubek: "The classification of phenotype characteristics in adult-onset spinal muscular atrophy" (European Neurology (2007); 58 (3): 170-176)
  15. M. Mühlau, C. Gaser, A. M. Wohlschläger, A. Weindl, M. Städtler, M Valet, C. Zimmer, J. Kassubek, A. Peinemann: "Striatal gray matter loss in Huntington Disease is leftward biased" (Movement Disorders (2007); 22 (8): 1169-1173)
  16. M. Sabolek, A. Unrath, A.-D. Sperfeld, B. J. Connemann, J. Kassubek: "Psychotische Störung unter Rofecoxib" (Psychiatrische Praxis (2007); 34 (4): 200-202)
  17. A. Riecker, H. Ackermann, J. Kassubek, B. Herrnberger, C. Steinbrink: "Bilateral language function in callosal agenesis: an fMRI and DTI study" (Journal of Neurology (2007); 254 (4): 528-530)
  18. D. Lulé, V. Diekmann, S. Anders, J. Kassubek, A. Kübler, A. C. Ludolph, N. Birbaumer: “Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS)” (Journal of Neurology (2007); 254 (4): 519-527)
  19. I. Uttner, A. Baumgartner, A.-D. Sperfeld, J. Kassubek: "Cognitive performance in pure and complicated hereditary spastic paraparesis: a neuropsychological and neuroimaging study" (Neuroscience Letters (2007); 419 (2): 158-161)
  20. J. Kassubek: "Häufige Komorbidität: Fast jeder zweite Parkinsonpatient wird dement" (NeuroTransmitter (2007); 18 (4); 64-65)
  21. G. Hirschfeld, A.-D. Sperfeld, J. Kassubek, K. Scharffetter-Kochanek, C. Sunderkötter: "Transiente globale Amnesie (TGA) während einer oralen Arzneimittelexposition" (Hautarzt (2007); 58 (2): 149-152)
  22. H.-P. Müller, A. Unrath, A. C. Ludolph, J. Kassubek: "Preservation of diffusion tensor properties during spatial normalization by use of tensor imaging and fiber tracking on a normal brain database" (Physics in Medicine and Biology (2007); 52 (6): N99-N109)
  23. M. Mühlau, A. Weindl, A. M. Wohlschläger, C. Gaser, M. Städtler, M Valet, C. Zimmer, J. Kassubek, A. Peinemann: "Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington Disease" (Journal of Neural Transmission (2007); 114 (3):367-372)
  24. A.-D. Sperfeld, A. Unrath, J. Kassubek: "Restless legs syndrome in hereditary spastic paraparesis" (European Neurology (2007); 57 (1): 31-35)

2006

  1. E. H. Pinkhardt, L. Tebartz van Elst, A. C Ludolph, J. Kassubek: "Amygdala size in amyotrophic lateral sclerosis without dementia: an in vivo study using MRI volumetry" (BMC Neurology (2006); 6 (1): 48 (1-6))
  2. J. Kassubek: "Parkinsonsyndrom und Demenz" (MMW - Fortschritte der Medizin (2006); 148 (51-52): 36-37)
  3. J. Brettschneider, A. Petzold, S. D. Süßmuth, G. B. Landwehrmeyer, A. C. Ludolph, J. Kassubek, H. Tumani: "The neurofilament heavy chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes" (Movement Disorders (2006); 21 (12): 2224-2227)
  4. C. Beetz, A. O. H. Nygren, J. Schickel, M. Auer-Grumbach, K. Bürk, G. Heide, J. Kassubek, S. Klimpe, T. Klopstock, F. Kreuz, S. Otto, R. Schüle, L. Schöls, A.-D. Sperfeld, O. W. Witte, T. Deufel: "High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia" (Neurology (2006); 67 (11): 1926-1930)
  5. A. Unrath, J. Kassubek: "Symptomatic restless leg syndrome after lacunar stroke: a lesion study" (Movement Disorders (2006); 21 (11): 2027-2028)
  6. K. Henkel, A. Danek, J. Grafman, J. Butman, J. Kassubek: "Head of the caudate nucleus is most vulnerable in chorea-acanthocytosis: a voxel-based morphometry study" (Movement Disorders (2006); 21 (10): 1728-1731)
  7. M. W. Riepe, J. Kassubek, F. Tracik, G. Ebersbach: "Screening for cognitive impairment in Parkinson’s disease - which marker relates to disease severity?" (Journal of Neural Transmission (2006); 113 (10): 1463-1468)
  8. R. Schüle, T. Holland-Letz, S. Klimpe, J. Kassubek, T. Klopstock, V. Mall, S. Otto, B. Winner, L. Schöls: "The spastic paraplegia rating scale (SPRS): a reliable and valid measure of disease severity" (Neurology (2006); 67 (3): 430-434)
  9. J. Kassubek, A.-D. Sperfeld, A. Baumgartner, H.-J. Huppertz, A. Riecker, F. D. Juengling: "Brain atrophy in pure and complicated hereditary spastic paraparesis: a quantitative 3-D MRI study" (European Journal of Neurology (2006); 13 (8): 880-886)
  10. J. Kassubek, F. D. Juengling, A. G. Ludolph: "Heterogeneity of voxel-based morphometry findings in Tourette syndrome: an effect of age?" (Annals of Neurology (2006); 59 (5): 872-873)
  11. A. G. Ludolph, F. D. Juengling, G. Libal, A. C. Ludolph, J. M. Fegert, J. Kassubek: "Grey matter abnormalities in boys with Tourette Syndrome: a 3-D MRI study using optimized voxel-based morphometry" (British Journal of Psychiatry (2006); 188 (5): 484-485)
  12. H.-J. Gdynia, J. Kassubek, A.-D. Sperfeld: „Laryngospasm in neurological diseases” (Neurocritical Care (2006); 4 (2); 163-167)
  13. I. Uttner, F. M. Mottaghy, H. Schreiber, A. Riecker, A. C. Ludolph, J. Kassubek: "Primary progressive aphasia accompanied by environmental sound agnosia: a neuropsychological, MRI and PET study" (Psychiatry Research Neuroimaging (2006); 146 (2): 191-197)
  14. A. Riecker, J. Kassubek, K. Groeschel, W. Grodd, H. Ackermann: "The cerebral control of speech tempo: opposite relationship between speaking rate and BOLD signal changes at striatal and cerebellar structures" (NeuroImage (2006); 29 (1): 46-53)
  15. T. Els, E. Oehm, S. Voigt, J. Klisch, A. Hetzel, J. Kassubek: "Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke" (Cerebrovascular Diseases (2006); 21 (1-2): 79-85)

2005 und früher

  1. R. Huber, J. Kassubek: "Minor trauma may lead to traumatic internal carotid artery dissection" (Neurocritical Care (2005); 3 (3): 254-256)
  2. A.-D. Sperfeld, A. Baumgartner, J. Kassubek: "Magnetic resonance investigation of the upper spinal cord in pure and complicated hereditary spastic paraparesis" (European Neurology (2005); 54 (4):181-185)
  3. J. Kassubek, A. Unrath, H.-J. Huppertz, D. Lulè, T. Ethofer, A.-D. Sperfeld, A. C. Ludolph: "Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI" (Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders (2005); 6 (4): 213-220)
  4. D. Lulè, A. Kurt, R. Jürgens, J. Kassubek, V. Diekmann, E. Kraft, N. Neumann, A. C. Ludolph, N. Birbaumer, S. Anders: "Emotional responding in amyotrophic lateral sclerosis" (Journal of Neurology (2005); 252 (12): 1517-1524)
  5. Peinemann, S. Schuller, C. Pohl, T. Jahn, A. Weindl, J. Kassubek: "Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study" (Journal of the Neurological Sciences (2005); 239 (1): 11-19)
  6. H.-J. Huppertz, C. Grimm, S. Fauser, J. Kassubek, I. Mader, A. Hochmuth, J. Spreer, A. Schulze-Bonhage: "Enhanced visualization of blurred gray-white matter junctions in focal cortical dysplasia by voxel-based 3-D MRI analysis" (Epilepsy Research (2005); 67 (1-2): 35-50)
  7. J. A. Kress, P. Kühnlein, P. Winter, A. C. Ludolph, J. Kassubek, U. Müller, A.-D. Sperfeld: "Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis" (Annals of Neurology (2005); 58 (5): 800-803)
  8. J. Brettschneider, A. Claus, J. Kassubek, H. Tumani: "Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases" (Journal of Neurology (2005); 252 (9): 1067-1073)
  9. D. Ecker, U. W. Geisthoff, M. Juchems, G. Schneider, A. C. Ludolph, J. Kassubek, R. Huber: "Hereditäre hämorrhagische Teleangiektasie - seltene Insultursache mit Behandlungsoption" (Nervenarzt (2005); 76 (8): 980-983)
  10. J. Kassubek, V. Bretschneider, A.-D. Sperfeld: "Corticospinal tract MRI hyperintensity in X-linked Charcot-Marie-Tooth disease" (Journal of Clinical Neuroscience (2005); 12 (5); 588-589)
  11. R. Wiest, J. Kassubek, K. Schindler, T. J. Loher, C. Kiefer, L. Mariani, M. Wissmeyer, G. Schroth, J. Mathis, B. Weder, F. D. Juengling: "Comparison of voxel-based 3-D MRI analysis and subtraction ictal SPECT coregistered to MRI in focal epilepsy" (Epilepsy Research (2005); 65 (1-2): 125-133)
  12. H.-P. Müller, I. DeCesaris, M. DeMelis, L. Marzetti, A. Pasquarelli, S. N. Ernè, A. C. Ludolph, J. Kassubek: "Open magnetic and electric graphic analysis: comprehensive magnetoencephalographic and functional magnetic resonance imaging in one single software environment" (IEEE Engineering in Medicine and Biology (2005); 24 (3): 109-116)
  13. J. Kassubek, F. D. Juengling, D. Ecker, G. B. Landwehrmeyer: "Thalamic atrophy in Huntington´s disease co-varies with cognitive performance: a morphometric MRI analysis" (Cerebral Cortex (2005); 15 (6): 846-853)
  14. J. Brettschneider, M. Maier, S. Arda, A. Claus, S. D. Süssmuth, J. Kassubek, H. Tumani: "Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis" (Multiple Sclerosis (2005); 11 (3): 261-265)
  15. A.-D. Sperfeld, V. Bretschneider, L. Flaith, A. Unrath, C. O. Hanemann, A. C. Ludolph, J. Kassubek: "MR-pathologic comparison of upper spinal cord in different motor neuron diseases" (European Neurology (2005); 53 (2): 74-77)
  16. A.-D. Sperfeld, C. O. Hanemann, A. C. Ludolph, J. Kassubek: "Laryngospasm: an underdiagnosed symptom of X-linked spinobulbar muscular atrophy" (Neurology (2005); 64 (4): 753-754)
  17. F. D. Juengling*, J. Kassubek*, H.-J. Huppertz, T. Krause, T. Els (* shared 1st authorship): "Separating functional and structural damage in persistent vegetative state using combined voxel-based analysis of 3-D MRI and FDG-PET" (Journal of the Neurological Sciences (2005); 228 (2): 179-184)
  18. Schönfeldt-Lecuona, R. W. Freudenmann, H. Tumani, J. Kassubek, B. J. Connemann: "Acute psychosis with a mediastinal carcinoma metastasis" (Medical Science Monitor (2005); 11 (1): CS6-8)

2004

  1. T. Els, J. Kassubek, R. Kubalek, J. Klisch: "Diffusion-weighted MRI during early global cerebral hypoxia: a predictor for clinical outcome?" (Acta Neurologica Scandinavica (2004); 110 (6): 361-367)
  2. A.-D. Sperfeld, J. Kassubek, A. H. Crosby, B. Winner, A. C. Ludolph, I. Uttner, C. O. Hanemann: "Complicated hereditary spastic paraplegia with thin corpus callosum: variation of phenotypic expression over time" (Journal of Neurology (2004); 251 (10): 1285-1287)
  3. R. Korinthenberg, C. Bauer-Scheid, P. Burkart, H. Martens-Le Bouar, J. Kassubek, F. D. Juengling: "18FDG-PET in epilepsies of infantile onset with pharmacoresistant generalised tonic-clonic seizures" (Epilepsy Research (2004); 60 (1): 53-61)
  4. J. Kassubek, G. Hickok, P. Erhard: "Involvement of classical anterior and posterior language areas in sign language production, as investigated by 4 T functional magnetic resonance imaging" (Neuroscience Letters (2004); 364 (3): 168-172)
  5. A.-D. Sperfeld, J. Kassubek, A. C. Ludolph: "Aktuelle Aspekte in der Diagnostik und Therapie der amyotrophen Lateralsklerose" (Aktuelle Neurologie (2004); 31: 209-215)
  6. J. Kassubek, G. B. Landwehrmeyer, D. Ecker, F. D. Juengling, R. Muche, S. Schuller, A. Weindl, A. Peinemann: "Global cerebral atrophy in early stages of Huntington´s disease: quantitative MRI study" (NeuroReport (2004); 15 (2): 363-365)
  7. J. Kassubek, F. D. Juengling, T. Kioschies, K. Henkel, J. Karitzky, B. Kramer, D. Ecker, J. Andrich, C. Saft, P. Kraus, A. J. Aschoff, A. C. Ludolph, G. B. Landwehrmeyer: "Topography of cerebral atrophy in early Huntington´s disease: a voxel-based morphometric MRI study" (Journal of Neurology, Neurosurgery and Psychiatry (2004); 75 (2): 213-220)
  8. J. Kassubek, W. Gaus, G. B. Landwehrmeyer: "Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis" (Neurology (2004); 62 (3): 523-524)
  9. J. Kassubek, B. J. Connemann: "Komorbidität depressiver Störungen II: Die Rolle von Erkrankungen des zentralen Nervensystems" (Nervenheilkunde (2004); 23: 116-121)
  10. J. Connemann, J. Kassubek: "Komorbidität depressiver Störungen I: Die Rolle von Achse-I- und Achse-II-Störungen" (Nervenheilkunde (2004); 23: 5-12)
  11. Schönfeldt-Lecuona, F. D. Juengling, B. J. Connemann, S. N. Reske, M. Spitzer, J. Kassubek: "Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol" (Journal of Clinical Psychopharmacology (2004); 24 (1): 97-98)

2003

  1. B. J. Connemann, J. Kassubek: "Psychiatric hospitalizations among survivors of cancer in childhood or adolescence" (New England Journal of Medicine (2003); 349 (19): 1868-1869)
  2. M. Wilke, J. Kassubek, S. Ziyeh, A. Schulze-Bonhage, H.-J. Huppertz: "Automated detection of gray matter malformations using optimized voxel-based morphometry: a systematic approach" (NeuroImage (2003); 20 (1): 330-343)
  3. D. Juengling, J. Kassubek: "Standardized calculation of brain parenchymal fraction: an approach to objective assessment of cerebral atrophy" (American Journal of Neuroradiology (2003); 24: 1492-1493)
  4. J. Kassubek, F. D. Juengling, S. Hoffmann, A. Rosenbohm, A. Kurt, K. Jurkat-Rott, P. Steinbach, M. Wolf, A. C. Ludolph, F. Lehmann-Horn, H. Lerche, Y. G. Weber: "Quantification of brain atrophy in myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study" (Neuroscience Letters (2003); 348 (2): 73-76)
  5. J. Kassubek, F. D. Juengling, T. Els, J. Spreer, M. Herpers, T. Krause, E. Moser, C. H. Lücking: "Activation of a residual cortical network during painful stimulation in long-term postanoxic vegetative state: a 15O-H2O PET study" (Journal of the Neurological Sciences (2003); 212 (1-2): 85-91)
  6. J. Kassubek, G. B. Landwehrmeyer, C. H. Lücking, F. D. Juengling: "Postischemic Holmes´ tremor investigated by FDG- and H215O-PET" (Journal of Radiology (2003); 6 (June): 1-8)
  7. J. Kassubek, H. Tumani, D. Ecker, A. Kurt, A. C. Ludolph, F. D. Juengling: "Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study" (NeuroReport (2003); 14 (3): 427-430)

2002

  1. D. Juengling, J. Kassubek, H. Martens-Le Bouar, M. J. Reinhardt, T. Krause, E. U. Nitzsche, E. Moser, R. Korinthenberg: "Cerebral regional hypometabolism caused by propofol-induced sedation in children with severe myoclonic epilepsy - a study uing fluorodeoxyglucose positron emission tomography and statistical parametric mapping" (Neuroscience Letters (2002); 335 (2): 79-82)
  2. P. Stiller, J. Kassubek, C. Schönfeldt-Lecuona, B. J. Connemann: "Wilson´s disease in psychiatric patients" (Psychiatry and Clinical Neurosciences (2002); 56: 649)
  3. C. Schönfeldt-Lecuona, H. Walter, B. J. Connemann, J. Kassubek, M. Spitzer, U. Herwig: "Geschichte und aktuelle Forschungstrends der antidepressiven repetitiven transkraniellen Magnetstimulation (rTMS)" (Fortschritte der Neurologie und Psychiatrie (2002): 70 (10): 520-530)
  4. J. Kassubek, F. D. Juengling: "Nuklearmedizinische Bildgebung in der Epilepsiediagnostik II: Rezeptordiagnostik und funktionelle Bildgebung" (Nervenheilkunde (2002); 21: 475-481)
  5. D. Juengling, J. Kassubek: "Nuklearmedizinische Bildgebung in der Epilepsiediagnostik I: Perfusion und Metabolismus" (Nervenheilkunde (2002); 21: 420-425)
  6. T. Els, A. Serr, J. Klisch, E. Oehm, C. H. Lücking, J. Kassubek: "Tuberkulöse Meningoenzephalitis: Klinisches Bild, Diagnostik und Behandlung" (Medizinische Klinik (2002); 97: 579-587)
  7. C. Bötefür, J. Kassubek, M. Schumacher: "Unusually quick resorption of an intracerebral hemorrhage in congenital afibrinogenemia" (Neuroradiology (2002); 44: 912-914)
  8. J. Kassubek, F. D. Juengling: "Results on coregistration of mediotemporal FDG-PET hyperactivity and 3D magnetic resonance imaging hyperintense lesions in limbic encephalitis" (Journal of Neuroimaging (2002); 12 (3): 282-283)
  9. J. Kassubek, H.-J. Huppertz, J. Spreer, A. Schulze-Bonhage: "Detection and localization of focal cortical dysplasia by voxel-based 3-D MRI analysis" (Epilepsia (2002); 43 (6): 596-602)
  10. Spreer, S. Arnold, A. Quiske, R. Wohlfarth, S. Ziyeh, D. Altenmueller, M. Herpers, J. Kassubek, J. Klisch, B. J. Steinhoff, J. Honegger, A. Schulze-Bonhage, M. Schumacher: "Determination of hemispheric dominance for language: comparison of frontal and temporal fMRI activation with intracarotid amytal testing" (Neuroradiology (2002); 44: 467-474)
  11. J. Kassubek, F. D. Juengling, A.-D. Sperfeld, A. Wunderlich, G. Grön: "Klinische Anwendung bildgebender Diagnostik bei fortgeschrittener frontotemporaler Lobaratrophie: 3D-MR-Morphometrie und PET" (Nervenheilkunde (2002); 21: 214-218)
  12. J. Kassubek, A.-D. Sperfeld, P. Satrapi, J. Fischer, C. Schönfeldt-Lecuona, B. J. Connemann: "Klinik und aktuelle Therapie des Gilles-de-la-Tourette-Syndroms" (Nervenheilkunde (2002); 21: 149-155)
  13. E. Oehm, T. Els, J. Spreer, J. Kassubek, A. Hetzel: "Transcranial color coded sonography in basilar artery stenting" (Ultrasound in Medicine and Biology (2002); 28 (3): 383-387)
  14. F. D. Juengling, J. Kassubek, S. Högerle, E. U. Nitzsche, E. Moser: "SMART-PET (Segmented MRI And Registered Talairach-transformed PET) - multimodality white matter imaging and display without loss of quantitative information" (Journal of Magnetic Resonance Imaging (2002); 15 (4): 456-461)
  15. J. Kassubek, F. D. Juengling, B. Hellwig, J. Spreer, C. H. Lücking: "Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging" (Neuroscience Letters (2002); 323 (1): 29-32)
  16. Knauff, T. Mulack, J. Kassubek, H. R. Salih, M. W. Greenlee: "Spatial imagery of deductive reasoning: a functional MRI study" (Cognitive Brain Research (2002); 13 (2): 203-212)
  17. T. van Elst, F. D. Juengling, J. Kassubek, K. Schmidtke, T. Thiel, D. Ebert, P. Dykierek, M. Hüll: "On the role of quantitative brain imaging in the differential diagnosis of speech disorders" (Psychiatry and Clinical Neurosciences (2002); 56: 111-115)
  18. F. Feuerhake, B. Volk, C. Ostertag, F. D. Juengling, J. Kassubek, M. Orszagh, M. Dichgans: "Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL" (Acta Neuropathologica (2002); 103: 188-192)

2001

  1. J. Kassubek, B. Zucker, E. Oehm, A. Serr, S. M. Arnold, C. H. Lücking, T. Els: "Tuberculous meningoencephalitis in HIV-seronegative patients: variety of clinical presentation and impact on diagnostics and treatment" (Acta Neurologica Scandinavica (2001); 104 (6): 389-396)
  2. H. Kimmig, M.W. Greenlee, M. Gondan, M. Schira, J. Kassubek, T. Mergner: "Relationship between saccadic eye movements and cortical activity as measured by fMRI: quantitative and qualitative aspects" (Experimental Brain Research (2001); 141: 184-194)
  3. J. Kassubek, F. D. Juengling, B. Hellwig, M. Knauff, J. Spreer, C. H. Lücking:
  4. "Hypermetabolism in the ventrolateral thalamus in unilateral Parkinsonian resting tremor: a positron emission tomography study" (Neuroscience Letters (2001); 304 (1-2): 17-20)
  5. F. D. Juengling, J. Kassubek, S. M. Weiner: "Cerebral glucose metabolism in Sneddon's syndrome associated with antiphospholipid antibodies" (Lupus (2001); 10: 309-310)
  6. J. Kassubek, K. Schmidtke, H. Kimmig, C. H. Lücking, M. W. Greenlee: "Changes in cortical activation during mirror reading before and after training: an fMRI study of procedural learning" (Cognitive Brain Research (2001); 10 (3): 207-217)
  7. J. Kassubek, F. D. Juengling, E. U. Nitzsche, C. H. Lücking: "Limbic encephalitis investigated by 18FDG-PET and 3D MRI" (Journal of Neuroimaging (2001); 11 (1): 55-59)
  8. Otte, F. D. Juengling, J. Kassubek: "Exceptional brain function in musicians and the neural basis of music processing" (European Journal of Nuclear Medicine (2001); 28 (1): 130-131

2000 und früher

  1. Knauff, J. Kassubek, T. Mulack, M. W. Greenlee: "Cortical activation evoked by visual mental imagery as measured by functional MRI" (NeuroReport (2000); 11 (18): 3957-3962)
  2. G. Schumann, U. Halsband, J. Kassubek, S. Gustin, T. Heinks, F. D. Juengling, M. Hüll: "Combined semantic dementia and apraxia in a patient with frontotemporal lobar degeneration" (Psychiatry Research Neuroimaging (2000); 100 (1): 21-29)
  3. Stippich, J. Kassubek, H. Kober, P. Sörös, J. B. Vieth: "Time course of focal slow wave activity in transient ischemic attacks and transient global amnesia as measured by magnetoencephalography" (NeuroReport (2000); 11 (15): 3309-3313)
  4. J. Kassubek, F. D. Juengling, A. Otte: "Improved interpretation of cerebral PET with respect to structural MRI changes using combined voxel-based statistical mapping" (European Journal of Nuclear Medicine (2000); 27: 880)
  5. G. Hickok, P. Erhard, J. Kassubek, A. K. Helms-Tillery, S. Naeve-Velguth, J. P. Strupp, P. L. Strick, K. Ugurbil: "A functional magnetic resonance imaging study of the role of left posterior superior temporal gyrus in speech production: implications for the explanation of conduction aphasia" (Neuroscience Letters (2000); 287 (2): 156-160)
  6. F. D. Juengling, J. Kassubek, A. Otte: "Standardization of cerebral PET imaging in clinical neurological diagnostics" (European Journal of Nuclear Medicine (2000); 27: 98)
  7. J. Kassubek, M. Obert, C. H. Lücking: "Superficial siderosis of the CNS: a late complication of cerebellar tumors" (Neurology (1999); 53 (8): 1893-1894)
  8. J. Kassubek, M. Otte, T. Wolter, M. W. Greenlee, T. Mergner, C. H. Lücking: "Brain imaging in a patient with hemimicropsia" (Neuropsychologia (1999); 37: 1327-1334)
  9. J. Kassubek, P. Sörös, H. Kober, C. Stippich, J. B. Vieth: "Focal slow and beta brain activity in patients with multiple sclerosis revealed by magnetoencephalography" (Brain Topography (1999); 11 (3): 193-200)
  10. F. D. Juengling, J. Kassubek, E. Moser, E. U. Nitzsche: "Precise localization of dysfunctional areas in vertebro-basilar infarction by FDG- and H215O-PET using standardized image analysis and image registration to 3-D MR" (Nuklearmedizin (1999); 38: 341-344)
  11. Lange, S. Aleksic, J. Kassubek, M. M. Vrvic, M. Kist, B. Steinbrückner, M. Mitova: "Detection of antibodies against Campylobacter jejuni serogroup PEN O:19 purified flagellar protein in a patient with Guillain-Barrè syndrome" (International Journal of Medical Microbiology, Virology, Parasitology and Infectious Diseases (1999); 289 (4): 429-444)
  12. Stippich, P. Freitag, J. Kassubek, P. Sörös, K. Kamada, H. Kober, K. Scheffler, R. Hopfengärtner, D. Bilecen, E.-W. Radü, J. Vieth: "Motor, somatosensory and auditory cortex localization by fMRI and MEG" (NeuroReport (1998); 9 (9): 1953-1957)
  13. K. Kamada, M. Möller, M. Saguer, J. Kassubek, M. Kaltenhäuser, H. Kober, M. Überall, H. Lauffer, D. Wenzel, J. Vieth: "Localization analysis of neuronal activities in benign rolandic epilepsy using magnetoencephalography" (Journal of the Neurological Sciences (1998); 154: 164-172)
  14. Ganslandt, R. Steinmeier, H. Kober, J. Vieth, J. Kassubek, J. Romstöck, C. Strauss, R. Fahlbusch: "Magnetic source imaging combined with image-guided frameless stereotaxy: a new method in surgery around the motor strip" (Neurosurgery (1997); 41: 621-628)
  15. K. Kamada, M. Möller, M. Saguer, J. Kassubek, H. Kober, D. Wenzel, J. Vieth: "Benign rolandic epilepsy investigated by magnetoencephalography" (Biomedizinische Technik (1997); 42 (Suppl. 1): 185-187)
  16. S. Engelhardt, W. Zieger, J. Kassubek, M. C. Michel, M. J. Lohse, O.-E. Brodde: "Tocolytic therapy with fenoterol induces selective downregulation of b-adrenergic receptors in human myometrium" (Journal of Clinical Endocrinology and Metabolism (1997); 82: 1235-1242)
  17. J. Kassubek, C. Stippich, P. Sörös, O. Ganslandt, K. Kamada, R. Hopfengärtner, H. Kober, R. Steinmeier, J. Vieth: "A motor field source localization protocol using magnetoencephalography" (Biomedizinische Technik (1996); 41 (Suppl. 1): 334-335)
  18. J. Kassubek, C. Stippich, P. Sörös, K. Kamada, H. Kober, R. Hopfengärtner, J. Vieth: "Magnetoencephalographic findings in patients with multiple sclerosis" (Biomedizinische Technik (1996); 41 (Suppl. 1): 308-309)
  19. C. Stippich, J. Kassubek, P. Sörös, O. Ganslandt, K. Kamada, H. Kober, R. Hopfengärtner, R. Steinmeier, J. Vieth: "Precise pre- and intraoperative assessment of functional cortex by magnetoencephalography" (Biomedizinische Technik (1996); 41 (Suppl. 1): 306-307)
  20. J. Kassubek, O. Witzke, E. Bonmann, E. Musch: "Alternating immune therapy in renal cell carcinoma" (Onkologie (1995); 18: 252-254)
  21. Witzke, J. Kassubek, E. Bonmann, E. Musch: "Cryoglobulinemia, a complication of infectious disease" (Clinical Investigator (1994); 72: 1048-1050)
  • A. C. Ludolph, P. Falkai, J. Kassubek: "Sonderband der Fortbildungsakademie der 122. Wanderversammlung 2006" (Pharma Service (Hannover); ISBN 3-9810999-1-5: 1-136
  • H.-P. Müller, J. Kassubek: "Multimodal imaging in neurology – special focus on MRI applications and MEG" (Lectures in Biomedical Engineering, BME brochure, Morgan & Claypool Publishers (San Rafael, CA, USA) 2008; ISBN: 1598295500 (paperback), 1598295519 (ebook): 1-75
  • C. Lang, J. Kassubek: “Schlafstörungen” (In: G. Höglinger (Ed.): Parkinson-Syndrome kompakt (1st Edition). Thieme (Stuttgart) 2018: 212-220)
  • J. Kassubek, H.-P. Müller, F. D. Juengling: "Multimodality in functional neuroimaging" (In: C. Stippich (Ed.): Clinical functional MRI - Presurgical functional neuroimaging (2nd Edition). Springer (Berlin / Heidelberg / New York / Dordrecht / London) 2015: 269-288)
  • R. Salazar-Montero, J. Kassubek: Neuroimaging in Non-Parkinson´s Disease tremor" (In: M. Filippi, J. Simon (Eds.): Imaging acute neurologic disease: a symptom-based approach. Cambridge University Press (Cambridge) 2014; 301-316)
  • U. Bittner, C. Lenk, J. Kassubek, H. Fangerau: "Die Tiefe Hirnstimulation" (In: A. Borkenhagen, A. Stirn, E. Brähler (Eds.): Body Modification. Medizinisch-Wissenschaftliche Verlagsgesellschaft (Berlin) 2014: 233-255)
  • H.-P. Müller, A. Unrath, A. Riecker, J. Kassubek: "Diffusion tensor imaging: analysis methods for group comparison in neurology" (In: L. L`Abate, D. A. Kaiser (Eds.): Handbook of Technology in Psychology, Psychiatry, and Neurology. Nova Science (New York) 2012: 251-274)
  • J. Kassubek, A. C. Ludolph: “Multimodality approach to neuroimaging in ALS / FTD” (In: M. Strong (Ed.): Amyotrophic lateral sclerosis and the frontotemporal dementias. Oxford University Press (Oxford) 2012; 199-208)
  • J. Kassubek, E. H. Pinkhardt: “Neuro-ophthalmological alterations in patients with movement disorders” (In: N. Galvez-Jimenez, P. J. Tuite (Eds.): Uncommon Causes of Movement Disorders. Cambridge University Press (Cambridge/New York/Melbourne) 2011: 306-315)
  • A. G. Ludolph, J. Kassubek: "Tic-Störungen und Tourette-Syndrom" (In: J. M. Fegert, A. Streeck-Fischer, H. J. Freyberger (Eds.): Kompendium Adoleszenzpsychiatrie. Schattauer (Stuttgart/New York) 2011: 67-86)
  • J. Kassubek, A. Unrath: "CT und MRT in der Diagnostik von Parkinsonsyndromen" (In: W. Jost (Ed.): Diagnostik des Parkinsonsyndroms. Unimed (Bremen) 2008; 71-79)
  • K. Henkel, M. Walterfang, D. Velakoulis, A. Danek, J. Kassubek: "Volumetric neuroimaging in neuroacanthocytosis" (In: R. H. Walker, S. Saiki, A. Danek (Eds.): Neuroacanthocytosis syndromes II. Springer (Berlin/Heidelberg) 2008: 175-185)
  • J. Kassubek, F. D. Juengling: "Multimodality functional neuroimaging" (In: C. Stippich (Ed.): Clinical functional MRI - Presurgical functional neuroimaging. Springer (Berlin / Heidelberg / New York) 2007: 191-210)
  • H.-J. Huppertz, J. Kassubek, F. D. Juengling, J. Spreer, A. Schulze-Bonhage: ”Voxel-basierte 3D-MRT-Analyse zur Erkennung und Lokalisation fokaler kortikaler Dysplasien” (In: R. Korinthenberg (Ed.): Aktuelle Neuropädiatrie. Novartis Pharma Verlag (Nürnberg) 2003: 495-499)
  • S. N. Ernè, M. Demelis, A. Pasquarelli, A. Ludolph, H.-P. Müller, J. Kassubek: "MEG-fMRI multimodal imaging in one single software environment" (In: H. Nowak, J. Haueisen, F. Giessler, R. Huonker (Eds.): Proceedings of the 13th International Conference on Biomagnetism. VDE Verlag (Berlin, Offenbach) 2002: 872-874)
  • H. Kober, J. B. Vieth, C. Stippich, J. Kassubek, R. Hopfengärtner: ”Time course of abnormal MEG activity associated with transient ischemic attacks” (In: C. J. Aine, Y. Okada, G. Stroink, S. J. Swithenby, C. C. Wood (Eds.): Biomag96 - Proceedings of the Tenth International Conference on Biomagnetism. Springer-Verlag (New York / Heidelberg / Tokyo) 2000: 1033-1036)
  • J. Kassubek, T. Mergner: ”Neurologische Erkrankungen” (In: C. F. Dietrich, H. Rass (Eds.): Therapie-Ratgeber. Spitta / Demeter Verlag (Balingen) 1998: Kapitel 2/7, 1–64)
  • J. Kassubek, C. Stippich, P. Sörös, P. Freitag, H. Kober, K. Scheffler, K. Kamada, R. Hopfengärtner, E. W. Radü, J. Vieth: ”Comparison of magnetoencephalography and functional MRI in functional mapping of motor, auditory and somatosensory cortex” (In: H. Witte, U. Zwiener, B. Schack, A. Doering (Eds.): Quantitative and Topological EEG and MEG Analysis. Druckhaus Mayer Verlag (Jena / Erlangen) 1997: 47-49)